Profil

Ansseau Marc

See author's contact details
Main Referenced Co-authors
Pitchot, William  (137)
Hansenne, Michel  (77)
Legros, Jean-Jacques  (62)
Scantamburlo, Gabrielle  (57)
Pinto, Emmanuel  (46)
Main Referenced Keywords
Humans (81); Male (81); Adult (76); Female (73); Middle Aged (40);
Main Referenced Unit & Research Centers
Centre de Neurosciences Cognitives et Comportementales - ULiège [BE] (15)
Centre de Neurosciences Comportementale et Cognitive (6)
ULg - Université de Liège (1)
Main Referenced Disciplines
Psychiatry (251)
Treatment & clinical psychology (112)
Neurosciences & behavior (67)
Neurology (23)
Pharmacy, pharmacology & toxicology (19)

Publications (total 482)

The most downloaded
13950 downloads
Licitsyna, O., ANSSEAU, M., & PITCHOT, W. (2011). Effets secondaires sexuels des antidépresseurs. Revue Médicale de Liège. https://hdl.handle.net/2268/89702

The most cited

1745 citations (Scopus®)

Lorant, V., Deliege, D., Eaton, W., Robert, A., Philippot, P., & Ansseau, M. (15 January 2003). Socioeconomic inequalities in depression: A meta-analysis [letter to the editor]. American Journal of Epidemiology, 157 (2), 98-112. doi:10.1093/aje/kwf182 https://hdl.handle.net/2268/256539

Panichelli, C., Albert, A., Donneau, A.-F., D'Amore, S., Triffaux, J.-M., & Ansseau, M. (2018). Humor Associated with Positive Outcomes in Individual Psychotherapy. American Journal of Psychotherapy, APT-2018-0021. doi:10.1176/appi.psychotherapy.20180021
Peer Reviewed verified by ORBi

Hanssens, L., Lustygier, V., ANSSEAU, M., Thiebaut, I., & Thimpont, J. (2017). La semaine motivationnelle : Une nouvelle approche dans le sevrage tabagique. Revue des Maladies Respiratoires, 34 (3), 188-193. doi:10.1016/j.rmr.2016.06.006
Peer Reviewed verified by ORBi

Ansseau, M., Scantamburlo, G., & PITCHOT, W. (2017). Antidépresseurs. In J. Guelfi & F. Rouillon, Manuel de Psychiatrie (pp. 603-614). Issy-les-Moulineaux, France: Elsevier Masson.
Peer reviewed

Demaret, I., Quertemont, E., Litran, G., Magoga, C., Deblire, C., DUBOIS, N., Charlier, C., Lemaître, A., & ANSSEAU, M. (June 2016). Loss of treatment benefit when heroin-assisted treatment is stopped after 12 month. Journal of Substance Abuse Treatment, 69, 72-75. doi:10.1016/j.jsat.2016.06.005
Peer Reviewed verified by ORBi

Scantamburlo, G., Vierset, V., Bonnet, P., Verpoorten, D., Delfosse, C., & Ansseau, M. (April 2016). VIGNETTE DIAGNOSTIQUE DE L'ETUDIANT. LogBook Numérique : Un carnet de bord réflexif comme outil d'apprentissage en contexte de stage. Revue Médicale de Liège, 71 (4), 210-215.
Peer reviewed

HITABATUMA, H., & ANSSEAU, M. (2016). Hypnose et psychiatrie: actualités et imagerie [Poster presentation]. 14ème Congrès de L'ENCEPHALE, Paris, France.

Vanmeerbeek, M., Remmen, R., Godderis, L., Van Casteren, V., Lambrechts, M.-C., Mairiaux, P., Lemaître, A., ANSSEAU, M., Peremans, L., Dom, G., Ketterer, F., Pirenne, D., Demaret, I., Boffin, N., Antoine, J., Van Royen, K., & Symons, L. (2015). “Up To Date” Use of psychoactive substances in adults: Prevention and Treatment by general practitioners and Occupational physicians; DATa retriEval. (DR/00/60). Bruxelles, Belgium: Belspo.

Demaret, I., Quertemont, E., Litran, G., Magoga, C., Deblire, C., DUBOIS, N., De Roubaix, J., Charlier, C., Lemaître, A., & Ansseau, M. (01 April 2015). Efficacy of heroin-assisted treatment in Belgium: a randomised controlled trial. European Addiction Research, 21 (4), 179-187. doi:10.1159/000369337
Peer Reviewed verified by ORBi

Ledent, M., Beauvois, V., Demaret, I., ANSSEAU, M., & SCANTAMBURLO, G. (April 2015). Champs électriques et magnétiques et santé : quel message au grand public ? Revue Médicale de Liège, 70 (4), 172-178.
Peer reviewed

Lemaire, B., Geron, D., MALAISE, O., Krzesinski, J.-M., Ansseau, M., & Scantamburlo, G. (April 2015). La dépression est une complication fréquente du lupus érythémateux disséminé : considérations épidémiologiques, pathogéniques et thérapeutiques. Revue Médicale de Liège, 70 (4), 215-218.
Peer reviewed

Demyttenaere, K., Donneau, A.-F., Albert, A., ANSSEAU, M., Constant, E., & vanHeeringen, K. (March 2015). What is important in being cured from depression? Discordance between physicians and patients (1). Journal of Affective Disorders, 174 (2015), 390-396. doi:10.1016/j.jad.2014.12.004
Peer Reviewed verified by ORBi

Demyttenaere, K., Donneau, A.-F., Albert, A., ANSSEAU, M., Constant, E., & van Heeringen, K. (March 2015). What is important in being cured from: Does discordance between physicians and patients matter? (2). Journal of Affective Disorders, 174 (2015), 372 - 377. doi:10.1016/j.jad.2014.12.002
Peer Reviewed verified by ORBi

DUBOIS, N., HALLET, C., SEIDEL, L., Demaret, I., LUPPENS, D., ANSSEAU, M., Rozet, E., Albert, A., Hubert, P., & Charlier, C. (2015). Estimation of the Time Interval between the Administration of Heroin and the Sampling of Blood in Chronic Inhalers. Journal of Analytical Toxicology. doi:10.1093/jat/bkv001
Peer Reviewed verified by ORBi

Scantamburlo, G., Vierset, V., Bonnet, P., Verpoorten, D., Delfosse, C., & Ansseau, M. (2015). eLogBook,un outil d'apprentissage en contexte de stage [Poster presentation]. Congrès de l'Encéphale.

Scantamburlo, G., Hansenne, M., Geenen, V., Legros, J.-J., & Ansseau, M. (January 2015). Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial. European Psychiatry, 30 (1), 65-68. doi:10.1016/j.eurpsy.2014.08.007
Peer Reviewed verified by ORBi

LUPPENS, D., PIETTE, C., RADERMECKER, R., SCANTAMBURLO, G., ANSSEAU, M., & PITCHOT, W. (November 2014). Dépression et diabète de type 2. Analyse étiopathogènique d'une comorbidité fréquente. Revue Médicale de Liège, 69 (11), 611-617.
Peer reviewed

ANSSEAU, M., & Demaret, I. (04 May 2014). Heroin-assisted treatment showed better efficacy than methadone [Poster presentation]. 167th American Psychiatric Association Annual Meeting, New-York, United States.

Lemaître, A., ANSSEAU, M., & Demaret, I. (2014). Projet TADAM: Conclusions scientifiques et recommandations. Lettre du RESPADD, (18), 2-4.

Demaret, I., Litran, G., Magoga, C., Deblire, C., Dupont, A., De Roubaix, J., Lemaître, A., & ANSSEAU, M. (22 March 2014). Why do heroin users refuse to participate in a heroin-assisted treatment trial? Heroin Addiction and Related Clinical Problems, Epub ahead of print, March 22, 2014.
Peer reviewed

RAMAEKERS, V., Thony, B., Sequeira, J. M., Ansseau, M., Philippe, P., BOEMER, F., Bours, V., & Quadros, E. V. (2014). Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies. Molecular Genetics and Metabolism, 113 (4), 307-14. doi:10.1016/j.ymgme.2014.10.002
Peer Reviewed verified by ORBi

SCHENA, A., Ansseau, M., TRIFFAUX, J.-M., Salmon, E., WITHOFS, N., & Scantamburlo, G. (2014). Le cas clinique du mois : Pseudo-démence dépressive. Revue Médicale de Liège, 69 (2), 64-67.
Peer reviewed

Esch, P., Bocquet, V., Pull, C., Couffignal, S., Lehnert, T., Graas, M., Fond-Harmant, L., & ANSSEAU, M. (2014). The downward spiral of mental disorders and educational attainment: A systematic review on early school leaving. BMC Psychiatry, 14 (1). doi:10.1186/s12888-014-0237-4
Peer Reviewed verified by ORBi

Ansseau, M. (2014). Heroin-assisted Tx superior to methadone for heroin addiction. Medscape medical news.
Peer reviewed

ESCH, P., BOCQUET, V., PULL, C., DEMONGEOT, C., LEHNERT, T., GRAAS, M., FOND-HARMANT, L., & Ansseau, M. (2014). Santé mentale et éducation au Luxembourg: Etude des facteurs de risque psychosociaux associés au décrochage scolaire. In Prévention et promotion de la santé mentale: Une alliance transfrontalière innovante (pp. 20-41). L'Harmattan.
Peer reviewed

Demaret, I., Litran, G., Magoga, C., Deblire, C., Van Caillie, D., Lemaître, A., ANSSEAU, M., Quertemont, E. (Other coll.), DUBOIS, N. (Other coll.), CHARLIER, C. (Other coll.), & De Roubaix, J. (Other coll.). (2013). Projet TADAM: RAPPORT FINAL 2007-2013. Liège, Belgium: ULg - Université de Liège.

DUBOIS, N., HALLET, C., SEIDEL, L., Rozet, E., LUPPENS, D., ANSSEAU, M., Hubert, P., Albert, A., & Charlier, C. (October 2013). Estimation du délai entre la consommation d'héroïne et le prélèvement chez des consommateurs chroniques [Poster presentation]. 5èmes Journées Internationales de Toxicologie, Liège, Belgium.

Demaret, I., Lemaître, A., & Ansseau, M. (May 2013). L'héroïne. Revue Médicale de Liège, 68 (5-6), 287.
Peer reviewed

Scantamburlo, G., & Ansseau, M. (2013). Traitement du trouble bipolaire de type II. In J.-M. Aubry, F. FERRERO, ... N. SCHAAD (Eds.), Psychopharmacologie des Troubles Bipolaires (pp. 331-336). Genève, Switzerland: Médecine et Hygiène.
Peer reviewed

DUBOIS, N., HALLET, C., LUPPENS, D., ANSSEAU, M., & Charlier, C. (2013). Sevrage rapide aux opiacés sous anesthésie (RODA). Revue Médicale de Liège, 68 (5-6), 298-302.
Peer reviewed

SCANTAMBURLO, G., PITCHOT, W., & Ansseau, M. (2013). La dependance affective. Revue Médicale de Liège, 68 (5-6), 340-7.
Peer reviewed

DUBOIS, N., Demaret, I., ANSSEAU, M., Rozet, E., Hubert, P., & Charlier, C. (2013). Plasma level monitoring of the major metabolites of diacetylmorphine (heroin) by the "chasing the dragon" route in severe heroin addicts. Acta Clinica Belgica, 68 (5), 359-367. doi:10.2143/ACB.3323
Peer Reviewed verified by ORBi

DUBOIS, N., HALLET, C., SEIDEL, L., LUPPENS, D., ANSSEAU, M., Hubert, P., Albert, A., & Charlier, C. (2013). Estimation du délai entre la consommation d'héroïne et le prélèvement chez des consommateurs chroniques. Acta Clinica Belgica, 68 (6), 481.

Scantamburlo, G., ANSSEAU, M., Geenen, V., & Legros, J.-J. (2013). AMELIORATION DE L’HUMEUR ET DE L’ANXIETE SOUS OCYTOCINE DANS LA DEPRESSION: ETUDE PILOTE. Encéphale (L').
Peer Reviewed verified by ORBi

BAKAY, S., IWEINS, A., Scantamburlo, G., Ansseau, M., & PITCHOT, W. (2013). Comment je traite ...la prise en charge de l'agitation en urgence. Revue Médicale de Liège, 68 (11), 553-6.
Peer reviewed

VANDER LAENEN, F., VANDERPLASSCHEN, W., SMET, V., DE MAEYER, J., BUCKINX, M., VAN AUDENHOVE, S., Ansseau, M., & DE RUYVER, B. (2013). Analysis and optimization of substitution treatment in Belgium (SUBANOP). Gent, Belgium: Academia Press.

PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2013). Complications psychiatriques et addictions. Revue Médicale de Liège, 68 (5-6), 218-20.
Peer reviewed

Destoop, M., van den Eede, F., Ansseau, M., Albert, A., Vanbelle, S., Mignon, A., Slachmuylders, P., & Sabbe, B. (2013). Prevalence and clinical characteristics of remission during treatment in generalized anxiety. International Journal of Psychiatry in Clinical Practice, 17 (2), 90-7. doi:10.3109/13651501.2013.784789
Peer Reviewed verified by ORBi

LE BON, O., Hansenne, M., AMARU, D., Albert, A., Ansseau, M., & DUPONT, S. (2013). Assortative mating and personality in human couples : A study using Cloninger's Temperament and Character Inventory. Psychology, 4 (1), 11-18. doi:10.4236/psych.2013.41002
Peer reviewed

Scantamburlo, G., Ansseau, M., Geenen, V., & Legros, J.-J. (2013). INTRANASAL OXYTOCIN IN THE TREATMENT OF MAJOR DEPRESSION: A PILOT STUDY [Poster presentation]. GIGA-Day.

SCHOLL, J.-M., Philippe, P., Gérard, P., Magis, D., Nadel, J., Ansseau, M., & Delvenne, V. (20 December 2012). Duration perception: A Developmental Semiology from 2:6 to 13 Years, General Population versus Atypical, Assessment by Parental Questionnaire [Paper presentation]. 12e Journée des Doctorants, Bruxelles, Belgium.

Ansseau, M., SEIDEL, L., CROSSET, A., DIERCKXSENS, Y., & Albert, A. (2012). A dry extract of passiflora incarnata L. (Sedanxio) as first intention treatment of patients consulting for anxiety problems in general practice. Acta Psychiatrica Belgica, 112 (2), 5-11.
Peer Reviewed verified by ORBi

LICITSYNA, O., Ansseau, M., GERNAY, D., PITCHOT, W., & Bertrand, J. (2012). Sexual dysfunction induced by antidepressants and antipsychotics. Terapevticheskii Arkhiv, 84 (10), 103-8.
Peer Reviewed verified by ORBi

PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2012). Approche clinique et therapeutique de la depression chez la personne agee. Revue Médicale de Liège, 67 (11), 566-72.
Peer reviewed

BAKAY, S., Scantamburlo, G., Ansseau, M., & PITCHOT, W. (2012). L'image du mois. Ingestion volontaire de corps etrangers: aspects psychiatriques. Revue Médicale de Liège, 67 (3), 105-106.
Peer reviewed

Mendlewicz, J., Crisafulli, C., Calati, R., Kocabas, A., Massat, I., LInotte, S., Kasper, S., Fink, M., Sidoti, A., Scantamburlo, G., Ansseau, M., Antonijevic, I., Forray, C., Snyder, L., Bollen, J., Montgomery, S., Zohar, J., Souery, D., & Serritti, A. (2012). Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression. Neuroscience Letters, 85-88. doi:10.1016/j.neulet.2012.03.063
Peer Reviewed verified by ORBi

Demaret, I., Lemaître, A., & ANSSEAU, M. (2012). Staff concerns in heroin-assisted treatment centres. Journal of Psychiatric and Mental Health Nursing, 19, 563-567. doi:10.1111/j.1365-2850.2011.01810.x
Peer Reviewed verified by ORBi

PITCHOT, W., & Ansseau, M. (2012). Efficacy of quetiapine in treatment-resistant panic disorder: a case report. Asian Journal of Psychiatry, 5 (2), 204-205. doi:10.1016/j.ajp.2012.02.013
Peer Reviewed verified by ORBi

PITCHOT, W., Scantamburlo, G., Ansseau, M., & Souery, D. (2012). Le trouble bipolaire: une affection bien complexe. Revue Médicale de Liège, 67 (5-6), 366-373.
Peer reviewed

DEBABECHE, C., Ansseau, M., & PITCHOT, W. (2012). Etat de stress post-traumatique et debriefing psychologique: un sujet controverse. Revue Médicale de Liège, 67 (1), 11-5.
Peer reviewed

Ansseau, M., & PITCHOT, W. (2012). Les antidépresseurs. In F. Rouillon (Ed.), Manuel de Psychiatrie (2ème édition, pp. 575-586). Elsevier Masson.

Desseilles, M., Phillips, C., Matthews, Dang-Vu, T. T., Sterpenich, V., Albouy, G., Schmidt, C., Darsaud, A., Salmon, E., Vandewalle, G., Balteau, E., Degueldre, C., Luxen, A., ANSSEAU, M., Schwartz, S., & Maquet, P. (June 2011). Locus-coeruleus activation in patients with major depression and suicidal ideations. Abstract book of the conference [Paper presentation]. 17th Annual Meeting of the OHBM (Organization for Human Brain Mapping), Quebec, Canada.

SCHOLL, J.-M., PHILIPPE, P., Pérée, F., Zdanowicz, N., & ANSSEAU, M. (April 2011). Une nouvelle conception des études sémiologiques : « l’épidémiologie sémiologique développementale ». Information Psychiatrique, 87 (4), 313-320. doi:10.1684/ipe.2011.0777
Peer Reviewed verified by ORBi

Du Four, V., Ledent, M., Lilien, J.-L., & ANSSEAU, M. (2011). How as a transmission system operator (TSO) to respond to the growing public concern on the potential health effects of ELF exposure ? In Proceedings of the 2d International Conference on Extremely Low Frequency Electric and Magnetic fields (pp. 10).
Peer reviewed

Demaret, I., Herné, P., Lemaître, A., & ANSSEAU, M. (March 2011). Feasibility assessment of heroin-assisted treatment in Liège, Belgium. Acta Psychiatrica Belgica, 111 (1), 3-8.
Peer Reviewed verified by ORBi

Licitsyna, O., ANSSEAU, M., & PITCHOT, W. (2011). Effets secondaires sexuels des antidépresseurs. Revue Médicale de Liège.
Peer reviewed

Scantamburlo, G., Ansseau, M., Geenen, V., & Legros, J.-J. (2011). Intranasal oxytocin as an adjunct to escitalopram in major depression. Journal of Neuropsychiatry and Clinical Neurosciences, 23 (2), 5. doi:10.1176/jnp.23.2.jnpe5
Peer Reviewed verified by ORBi

Noro, M., Linotte, S., Ansseau, M., Balériaux, D., Kavec, M., Mendlewicz, J., Metens, T., Scantamburlo, G., Souery, D., Verbanck, P., Peigneux, P., & Massat, I. (2011). Exploration neurodéveloppementale de la mémoire de travail par neuroimagerie fonctionnelle. Encéphale (L'), 37, 179-180.
Peer Reviewed verified by ORBi

PITCHOT, W., SOUERY, D., & Ansseau, M. (2011). La dépression résistante : Définition et diagnostic. Acta Psychiatrica Belgica, 111 (4), 13-19.
Peer Reviewed verified by ORBi

Demyttenaere, K., Ansseau, M., Constant, E., Albert, A., Van Gassen, G., & van Heeringen, K. (2011). Do general practitioners and psychiatrists agree about defining cure from depression? The DEsCRIBE (TM) survey. BMC Psychiatry, 11, 169. doi:10.1186/1471-244X-11-169
Peer Reviewed verified by ORBi

HITABATUMA, H., Papart, P., WAUTHY, J., BARTHOLOME, F., & Ansseau, M. (2011). Le modèle psychologique de Cloninger (TCI) et la dépression. Acta Psychiatrica Belgica, 111 (3), 34-38.
Peer Reviewed verified by ORBi

PITCHOT, W., SCANTAMBURLO, G., & ANSSEAU, M. (2011). La dépression résistante : Définition et diagnostique. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

HAIDON, M., PIETTE, C., ANSSEAU, M., & PITCHOT, W. (2011). Les troubles psychotiques dans les démences : quand la psychiatrie croise la neurologie. Acta Psychiatrica Belgica, 111 (11), 22-28.
Peer Reviewed verified by ORBi

PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2011). Les antidépresseurs du futur : rôle du système glutamatergique. Revue Médicale de Liège, 66 (4), 195-198.
Peer reviewed

PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2011). Le cas clinique du mois. Syndrome sérotoninergique induit par une association isoniazide/venlafaxine. Revue Médicale de Liège, 66 (12), 611-613.
Peer reviewed

DEBABECHE, C., PIETTE, C., Ansseau, M., & PITCHOT, W. (2011). Le coma psychogène. Acta Psychiatrica Belgica, 111 (3), 20-25.
Peer Reviewed verified by ORBi

Desseilles, M., Schwartz, S., Dang Vu, T. T., Sterpenich, V., Ansseau, M., Maquet, P., & Phillips, C. (2011). Depression alters "top-down" visual attention: a dynamic causal modeling comparison between depressed and healthy subjects. NeuroImage, 54 (2), 1662-8. doi:10.1016/j.neuroimage.2010.08.061
Peer Reviewed verified by ORBi

PITCHOT, W., SCANTAMBURLO, G., & ANSSEAU, M. (2011). Les antidépresseurs tricycliques et les IMAO ont-ils encore une place dans le traitement de la dépression? Revue Médicale de Liège.
Peer reviewed

Esch, P., Bocquet, V., Pull, C., Couffignal, S., Graas, M., Lair, M.-L., Lehnert, T., Fond-Harmant, L., & Ansseau, M. (2011). Psychosocial risk and protective factors of secondary school dropout in Luxembourg: the protocol of an exploratory case-control study. BMC Public Health, 11, 555. doi:10.1186/1471-2458-11-555
Peer Reviewed verified by ORBi

Licitsyna, O., ANSSEAU, M., & PITCHOT, W. (2011). Dysfonctions sexuelles et antidépresseurs. Revue Médicale de Liège, 66 (2), 69-74.

Demaret, I., Lemaître, A., & Ansseau, M. (December 2010). L’efficacité du traitement assisté par diacétylmorphine (héroïne pharmaceutique) à l’étranger. Revue Médicale de Liège, 65 (12), 681-687.
Peer reviewed

Demaret, I., Litran, G., ANSSEAU, M., & Lemaître, A. (08 September 2010). Heroin-Assisted Treatment as a treatment of criminal behaviour? [Paper presentation]. 10th Annual Conference of the European Society of Criminology - Crime and Criminology: from Individuals to Organizations, Liège, Belgium.

Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang-Vu, T., Albouy, G., Schmidt, C., Degueldre, C., Phillips, C., Ansseau, M., Maquet, P., & Schwartz, S. (June 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients. Abstract Book of the congress [Paper presentation]. World Congress of Behavioral and Cognitive Therapies (WCBCT), Boston, United States.

Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang-Vu, T., Albouy, G., Schmidt, C., Degueldre, C., Phillips, C., Ansseau, M., Maquet, P., & Schwartz, S. (May 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients.Abstract Book of the conference [Paper presentation]. 163rd Annual Meeting of the American Psychiatric Association (APA), New- Orleans J, United States.

Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang Vu, T. T., Albouy, G., Schmidt, C., Degueldre, C., Phillips, C., Ansseau, M., Maquet, P., & Schwartz, S. (April 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients. Abstract Book of the conference [Paper presentation]. 17th Annual Meeting of the Cognitive Neuroscience Society, Montreal, Canada.

Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang-Vu, T., Schmidt, C., Ansseau, M., Maquet, P., & Schwartz, S. (March 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients. Abstract Book of the conference [Paper presentation]. Swiss Society of Neurosciences (SSN) Annual Meeting 2010, Lausanne, Switzerland.

Maquet, D., Croisier, J.-L., Dupont, C., Moutschen, M., Ansseau, M., Zeevaert, B., & Crielaard, J.-M. (2010). Fibromyalgia and related conditions: Electromyogram profile during isometric muscle contraction. Joint Bone Spine, 77, 264–267. doi:10.1016/j.jbspin.2010.02.003
Peer Reviewed verified by ORBi

Scantamburlo, G., Ansseau, M., Geenen, V., & Legros, J.-J. (2010). Intranasal oxytocin as an antidepressant/anxiolytic hormone in the treatment of major depression: a case report.

PITCHOT, W., SCANTAMBURLO, G., & ANSSEAU, M. (2010). Duloxetine in major depressed patients resistant to SSRI and/or venlafaxine. Psychiatria Danubina.
Peer Reviewed verified by ORBi

Maquet, D., Croisier, J.-L., Dupont, C., Moutschen, M., Ansseau, M., Zeevaert, B., & Crielaard, J.-M. (2010). Fibromyalgie et affections voisines : analyse du comportement électromyographique au cours d’un effort musculaire isométrique. Revue du Rhumatisme, 77, 296-300. doi:10.1016/j.rhum.2009.10.026
Peer Reviewed verified by ORBi

Quertemont, E., Blairy, S., & Ansseau, M. (2010). Effets du cannabis sur la santé psychologique. Regards Croisés sur le Cannabis. Mardaga.

Farcy, L., PIETTE, C., MAVROPOULOS, G., Pinto, E., Ansseau, M., & PITCHOT, W. (2010). Delirium et anorexie. Acta Psychiatrica Belgica, 110, 3-7.
Peer Reviewed verified by ORBi

Pitchot, W., & Ansseau, M. (2010). Aripiprazole, hypertension, and confusion. Journal of Neuropsychiatry and Clinical Neurosciences, 22 (1), 123.E33. doi:10.1176/appi.neuropsych.22.1.123-t.e33
Peer Reviewed verified by ORBi

BEVE, A., BECK, E., Pinto, E., & Ansseau, M. (2010). Le cas clinique du mois. Syndrome de sécrétion inappropriée d'hormone antidiurétique (SIADH) induit par le valproate de sodium. Revue Médicale de Liège, 65 (1), 6-9.
Peer reviewed

PITCHOT, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2010). Guérir la dépression : une question d'objectif et de détermination. Revue Médicale de Liège, 65 (5-6), 370-380.
Peer reviewed

Scantamburlo, G., Reggers, J., Hansenne, M., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2010). Ocytocine plamsatique et dimensions de personnalité dans la dépression unipolaire. Encéphale (L'), 36, 17.
Peer Reviewed verified by ORBi

Quertemont, E., Blairy, S., & Ansseau, M. (2010). Effets du cannabis sur la santé psychologique. In V. Seutin, J. Scuvée, ... E. Quertemont (Eds.), Regards croisés sur le cannabis (pp. 105-122). Wavre, Belgium: Mardaga.

Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang-Vu, T., Schmidt, C., Ansseau, M., Maquet, P., & Schwartz. (January 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients [Paper presentation]. Alpine Brain Imaging Meeting, Champéry, Switzerland.

Desseilles, M., Muselle, A., Devue, C., Balteau, E., Sterpenich, V., Dang-Vu, T. T., Albouy, G., Schmidt, C., Matarazzo, L., Mascetti, L., Foret, A., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (July 2009). Increased filtering of irrelevant information in obsessive-compulsive disorder (OCD) patient. Abstract Book [Paper presentation]. 1st Congress of International College of Affective Neurosciences, Florence, Italy.

Desseilles, M., Muselle, A., Devue, C., Balteau, E., Sterpenich, V., Dang-Vu, T. T., Albouy, G., Schmidt, C., Matarazzo, L., Mascetti, L., Foret, A., Degueldre, C., Luxen, A., Ansseau, M., Maquet, P., Schwartz, S., & Phillips, C. (June 2009). Abnormal neural filtering of irrelevant information in depressed patients [Poster presentation]. 15th Annual Meeting of the OHBM (Organization for Human Brain Mapping), San Francisco, United States.

Desseilles, M., Schwartz, S., & Ansseau, M. (2009). Méthode d’évaluation de l’efficacité des psychotherapies: impact de la neuroimagerie fonctionnelle [Paper presentation]. 7e congrès de l’Encéphale, Paris, France.

Pitchot, W., & Ansseau, M. (2009). Dependance au zolpidem et crise d'epilepsie. Revue Médicale de Liège, 64 (7-8), 407-8.
Peer reviewed

Scantamburlo, G., Ansseau, M., Geenen, V., & Legros, J.-J. (2009). Oxytocin: From milk ejection to maladaptation in stress response and psychiatric disorders. A psychoneuroendocrine perspective. Annales d'Endocrinologie, 70 (6), 449-54. doi:10.1016/j.ando.2009.09.002
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Gorwood, P., Boni, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2009). The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease? Alcohol, 43 (4), 271-5. doi:10.1016/j.alcohol.2009.02.006
Peer reviewed

Pinto, E., & Ansseau, M. (2009). Facteurs genetiques de l'alcoolo-dependance Revue des principales donnees de la litterature. Encéphale (L'), 35 (5), 461-9. doi:10.1016/j.encep.2008.03.008
Peer Reviewed verified by ORBi

Zelinka, V., Faymonville, M.-E., Pitchot, W., & Ansseau, M. (2009). L'hypnose dans la prise en charge des douleurs chroniques. Acta Psychiatrica Belgica, 109 (3), 21-28.
Peer Reviewed verified by ORBi

Desseilles, M., Thiry, J.-C., Monville, J.-F., Ansseau, M., & Makhinson, M. (2009). Electroconvulsive therapy for depression in a patient with an intracranial arachnoid cyst. Journal of ECT, 25 (1), 64-6. doi:10.1097/YCT.0b013e3181729268
Peer Reviewed verified by ORBi

Desseilles, M., Balteau, E., Sterpenich, V., Dang Vu, T., Darsaud, A., Vandewalle, G., Albouy, G., Salmon, E., Peters, F., Schmidt, C., Schabus, M., Gais, S., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (2009). Abnormal neural filtering of irrelevant visual information in depression. NeuroImage, 45 (Suppl. 1).
Peer Reviewed verified by ORBi

Desseilles, M., Scwartz, S., Dang Vu, T., Sterpenich, V., Albouy, G., Schmidt, C., Salmon, E., Darsaud, A., Vandewalle, G., Balteau, E., Degueldre, C., Luxen, A., Ansseau, M., & Maquet, P. (2009). Neurobiological bases of suicidality in major depression. World Journal of Biological Psychiatry, 9 (Suppl. 1).
Peer Reviewed verified by ORBi

Ansseau, M., Demyttenaere, K., Heyrman, J., Migeotte, A., Leyman, S., & Mignon, A. (2009). Objective: remission of depression in primary care The Oreon Study. European Neuropsychopharmacology, 19 (3), 169-76. doi:10.1016/j.euroneuro.2008.10.003
Peer Reviewed verified by ORBi

Desseilles, M., Schwartz, S., Ansseau, M., & Maquet, P. (January 2009). Neurobiological Bases of Suicidality in Major Depression Abstract Book of the conference [Paper presentation]. Alpine Brain Imaging Meeting, Champéry, Switzerland.

Desseilles, M., Balteau, E., Sterpenich, V., Dang Vu, T. T., Darsaud, A., Vandewalle, G., Albouy, G., Salmon, E., Peters, F., Schmidt, C., Schabus, M., Gais, S., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (2009). Abnormal neural filtering of irrelevant visual information in depression. Journal of Neuroscience, 29 (5), 1395-403. doi:10.1523/JNEUROSCI.3341-08.2009
Peer Reviewed verified by ORBi

Desseilles, M., Muselle, A., Devue, C., Balteau, E., Sterpenich, V., Dang Vu, T. T., Albouy, G., Schmidt, C., Matarazzo, L., Mascetti, L., Foret, A., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (2009). Increased filtering of irrelevant information in obsessive-compulsive disorder (OCD) patient [Poster presentation]. First Congress of International College of Affective Neurosciences, Firenza, Italy.

Desseilles, M., Balteau, E., Sterpenich, V., Dang-Vu, T. T., Darsaud, A., Vandewalle, G., Albouy, G., Salmon, E., Peters, F., Schmidt, C., Schabus, M., Gais, S., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (11 July 2008). Abnormal neural filtering of irrelevant information in depressed patients Abstract Book of the conference [Paper presentation]. Symposium of the International Master in Affective Neuroscience, Florence, Italy.

Moonen, G., Ansseau, M., & Scheen, A. (May 2008). Le cerveau dans tous ses etats. Revue Médicale de Liège, 63 (5-6), 229-30.
Peer reviewed

Desseilles, M., Balteau, E., Sterpenich, V., Dang-Vu, T. T., Darsaud, A., Vandewalle, G., Albouy, G., Salmon, E., Peters, F., Schmidt, C., Schabus, M., Gais, S., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (15 March 2008). Abnormal neural filtering of irrelevant information in depressed patients. Abstract Book of the congress [Paper presentation]. 1ère Journée de l'Ecole Doctorale en Médecine Clinique et Expérimentale FRS-FNRS, Bruxelles, Belgium.

Tortolani, I., Gayetot, D., Duquesne, P., Donneau, A.-F., Boxho, P., & Ansseau, M. (2008). L'augmentation des hospitalisations contraintes : un constat préoccupant. Acta Psychiatrica Belgica, 108, 11-19.
Peer Reviewed verified by ORBi

Pitchot, W., Paquay, C., & Ansseau, M. (2008). Le comportement suicidaire: facteurs de risque psychosociaux et psychiatriques. Revue Médicale de Liège, 63, 396-403.
Peer reviewed

Pitchot, W., Scantamburlo, G., & Ansseau, M. (2008). Dopamine et dépression: le neurotransmetteur oublié. Revue Médicale de Liège, 63, 378-384.
Peer reviewed

Ansseau, M., Fischler, B., Dierick, M., Albert, A., Leyman, S., & Mignon, A. (2008). Socio-economic correlates of generalized anxiety disorder and major depression in primary care : The GADIS II study (Generalized Anxiety and Depression Impact Survey II). Depression and Anxiety, 25, 506-513. doi:10.1002/da.20306
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Gorwood, P., BONI, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2008). The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol and Alcoholism, 43, 398-400. doi:10.1093/alcalc/agn015
Peer Reviewed verified by ORBi

Servais, S., Ansseau, M., Mikolajczak, G., & Desseilles, M. (2008). L'électroconvulsivothérapie en 2008. Revue Médicale de Liège, 63, 404-410.
Peer reviewed

Scantamburlo, G., Pitchot, W., Ansseau, M., & Legros, J.-J. (2008). Peptides neurohypophysaires et dépression unipolaire: quel avenir? Revue Médicale de Liège, 63, 385-390.
Peer reviewed

Desseilles, M., Ansseau, M., Maquet, P., & Schwartz, S. (2008). Rôle de l'attention et de l'émotion dans la perception visuelle : leurs implications dans les troubles neurocognitifs de la dépression. Acta Psychiatrica Belgica, 108, 20-24.
Peer Reviewed verified by ORBi

Desseilles, M., Maquet, P., Darsaud, A., Dang-Vu, T. T., Sterpenich, V., Albouy, G., Ansseau, M., & Schwartz, S. (2008). Anomalies du filtrage neuronal des informations non-relevantes chez les patients déprimés (PO31) [Paper presentation]. 6e Congrès de l'Encéphale, Paris, France.

Pitchot, W., & Ansseau, M. (2008). Shock-like sensations associated with duloxetine discontinuation. Annals of Clinical Psychiatry, 20 (3), 175. doi:10.1080/10401230802177664
Peer Reviewed verified by ORBi

Moonen, G., Ansseau, M., & Scheen, A. (2008). Editorial. Le cerveau dans tous ses états. Revue Médicale de Liège, 63, 229-230.
Peer reviewed

Pitchot, W., Polis, M.-H., Belachew, S., & Ansseau, M. (2008). Dépression et neuroplasticité. Revue Médicale de Liège, 63, 372-377.
Peer reviewed

hurlet, A., parent, M., Lecoq, A., & Ansseau, M. (2008). Un cas de folie à trois. Acta Psychiatrica Belgica, 108, 18-24.
Peer Reviewed verified by ORBi

Pitchot, W., Scantamburlo, G., & Ansseau, M. (2008). Les antidépresseurs dans la dépression bipolaire: attention aux risques. Revue Médicale de Liège, 63, 391-395.
Peer reviewed

Maquet, D., Jaspar, J., Lecart, M.-P., Faymonville, M., Crielaard, J.-M., Bève, E., Ansseau, M., Pinto, E., Haidon, M., & Croisier, J.-L. (2008). La marche du sujet fibromyalgique et d’un sujet dépressif est-elle différenciable ? Exploration de deux affections « voisines » à partir d’un accéléromètre tri-axial. Revue du Rhumatisme, 75, 1142.
Peer reviewed

Pitchot, W., Scantamburlo, G., Pinto, E., Hansenne, M., Reggers, J., Ansseau, M., & Legros, J.-J. (2008). Vasopressin-neurophysin and DST in major depression : Relationship with suicidal behavior. Journal of Psychiatric Research, 42, 684-688. doi:10.1016/j.jpsychires.2007.07.007
Peer Reviewed verified by ORBi

Pinto, E., Pitchot, W., & Ansseau, M. (2008). Les psychostimulants. Revue Médicale de Liège, 63, 411-416.
Peer reviewed

Ansseau, M., Scantamburlo, G., Pinto, E., & Pitchot, W. (2008). Neurobiologie et pharmacothérapie du trouble obsessionnel-compulsif. Revue Médicale de Liège, 63, 359-363.
Peer reviewed

Papart, P., Ansseau, M., & Bartholomé, F. (2008). Contingent negative variation abnormalities in posttraumatic stress disorder. European Neuropsychopharmacology, 18 (Suppl 4), 481-482.
Peer Reviewed verified by ORBi

Scantamburlo, G., Ansseau, M., & Legros, J.-J. (2008). Growth Hormone Response to Apomorphine and Clonidine Stimulation in Psychiatric Disorders. In New Human Growth hormone (pp. 135-145). New York, United States - New York: Nova Biomedical Book.
Peer reviewed

Desseilles, M., Maquet, P., Ansseau, M., & Schwartz, S. (15 December 2007). Attention and perception in depression assessed by functional magnetic resonance imaging [Paper presentation]. Lecture at the international session of “Cognitive functions and pharmacotherapy”, Wisla, Poland.

Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Marechal, P., Pequeux, C., Ansseau, M., & Legros, J.-J. (May 2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology, 32 (4), 407-410. doi:10.1016/j.psyneuen.2007.01.009
Peer Reviewed verified by ORBi

Lorant, V., Croux, C., Weich, S., Deliege, D., Mackenbach, J., & Ansseau, M. (April 2007). Depression and socio-econornic risk factors: 7-year longitudinal population study. British Journal of Psychiatry, 190, 293-298. doi:10.1192/bjp.bp.105.020040
Peer Reviewed verified by ORBi

Desseilles, M., Maquet, P., Dang Vu, T. T., Sterpenich, V., Vandewalle, G., Peters, F., Darsaud, A., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., & Schwartz, S. (April 2007). Effects of attention on emotional face processing in depression: a functional MRI study [Poster presentation]. Conference on Depression: Brain Causes - Body Consequences, London, United Kingdom.

Desseilles, M., Ansseau, M., Maquet, P., & Schwartz, S. (10 March 2007). Rôle de l’attention et de l’émotion dans la perception visuelle : implications pour les troubles neurocognitifs dans la dépression. Abstract Book of the congress [Paper presentation]. Meeting of the S.R.M.M.B. (Belgian Royal Society for Mental Medicine), Bruxelles, Belgium.

Pitchot, W., Pinto, E., Scantamburlo, G., & Ansseau, M. (March 2007). Duloxetine in major depressed patients resistant to SSRIs or venlafaxine. European Psychiatry, 22 (Suppl. 1), 242. doi:10.1016/j.eurpsy.2007.01.810
Peer Reviewed verified by ORBi

Gayetot, D., Ansseau, M., & Triffaux, J.-M. (February 2007). "Quand la dépression n'en finit pas... " Stratégies actuelles et perspectives thérapeutiques de la dépression résistante. Revue Médicale de Liège, 62 (2), 103-11.
Peer reviewed

Desseilles, M., Ansseau, M., Maquet, P., & Schwartz, S. (22 January 2007). Attention and perception in depression assessed by fonctional resonance imaging [Paper presentation]. Meeting of the Academic Anxiety Center, Maastricht, Netherlands.

Desseilles, M., Maquet, P., Sterpenich, V., Vandewalle, G., Peters, F., Dang-Vu, T. T., Darsaud, A., Degueldre, C., Ansseau, M., & Schwartz, S. (2007). Effects of attention and emotion on face processing in depression: a functional magnetic resonance imaging study [Paper presentation]. 20th ECNP (European College of Neuropsychopharmacology) Congress, Vienna, Austria.

Coton, X., Pinto, E., Reggers, J., Hansenne, M., Parent, M., & Ansseau, M. (2007). Impact de la personnalité sur l'intensité du syndrome de sevrage alcoolique : une étude préliminaire avec le modèle de Cloninger. Encéphale (L'), 33, 264-269. doi:10.1016/s0013-7006(07)92038-2
Peer Reviewed verified by ORBi

Scantamburlo, G., Ansseau, M., & Legros, J.-J. (2007). Neurophysins in mood disorders. In Neuropeptide Research Trends (pp. 229-241). New-York, United States - New York: Nova Biomedical Book.
Peer reviewed

Ansseau, M., & Pitchot, W. (2007). Les antidépresseurs. In J. D. Guelfi & F. Rouillon (Eds.), Manuel de Psychiatrie (pp. 504-515). Paris, France: Masson.

Pitchot, W., & Ansseau, M. (2007). Nouveautés dans le traitement des troubles de l'humeur. Acta Psychiatrica Belgica, 107, 21-22.
Peer Reviewed verified by ORBi

Desseilles, M., Maquet, P., Dang Vu, T. T., Sterpenich, V., Vandewalle, G., Peters, F., Darsaud, A., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., & Schwartz, S. (2007). Effects of attention on emotional face processing in depression : a functional MRI study [Poster presentation]. Conference on depression : brain causes - body consequences, London, United Kingdom.

Pitchot, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2007). Syndrome de discontinuation associé aux antidépresseurs. Revue Médicale de Liège, 62, 1-4.
Peer reviewed

Pitchot, W., & Ansseau, M. (2007). Les troubles de l'humeur: approche pharmacologique. Revue Médicale de Liège, 62 (S2), 21-4.
Peer reviewed

Le Bon, O., Cappeliez, B., Neu, D., Stulens, L., Hoffmann, G., Hansenne, M., Lambrecht, L., Ansseau, M., & Linkowski, P. (2007). Personality profile of patients with chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome, 14, 55-68. doi:10.1300/j092v14n01_06
Peer Reviewed verified by ORBi

Hadoun, K., Ansseau, M., Bertand, J., & Lejeune, J. (2007). Influence de l'âge du médecin généraliste sur la prise en charge de la dépression. Acta Psychiatrica Belgica, 107, 55-65. doi:10.1007/s10597-018-0335-8
Peer Reviewed verified by ORBi

Desseilles, M., Thiry, J. C., Abramowski, S., Pallincourt, R., Farcy, L., Zelinka, V., Fush, S., & Ansseau, M. (January 2007). Electroconvulsivothérapie chez un patient déprimé avec un kyste arachnoïdien intracrânien [Paper presentation]. 5e Congrès de l’Encéphale, Paris, France.

Scantamburlo, G., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2007). Therapeutic utilisations of vasopressin and oxytocin in mood disorders. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, 1, 157-161.
Peer reviewed

Pitchot, W., & Ansseau, M. (2007). Hypothalamo-growth hormone dysfunction in panic disorder. Acta Psychiatrica Belgica, 107, 21-22.
Peer Reviewed verified by ORBi

Foatelli, F.-M., Gernay, P., Lievens, I., & Ansseau, M. (December 2006). Le cas clinique du mois. Syndrome malin des neuroleptiques et paralysie generale. Revue Médicale de Liège, 61 (12), 807-11.
Peer reviewed

Desseilles, M., Ansseau, M., Maquet, P., & Schwartz, S. (18 November 2006). Effects of attention on emotional face processing in depression: a functional MRI study. Abstract Book of the congress [Paper presentation]. Highlights in psychiatry 2006 session, Bruxelles, Belgium.

Desseilles, M., Maquet, P., Sterpenich, V., Vandewalle, G., Peters, F., Darsaud, A., Degueldre, C., Luxen, A., Ansseau, M., & Schwartz, S. (18 November 2006). Effects of attention on emotional face processing in depression: an fMRI study [Poster presentation]. Highlights in Psychiatry, Brussels, Belgium.

Papart, P., Liota, F., Bartholome, F., & Ansseau, M. (September 2006). Cognitive topography imbalance in alcoholism and psychiatric comorbidity. European Neuropsychopharmacology, 16 (Suppl. 4), 496. doi:10.1016/S0924-977X(06)70671-X
Peer Reviewed verified by ORBi

Ansseau, M., Reggers, J., Somers, L., Richy, F., Van Deun, P., & Sabbe, B. (September 2006). Meta-analyses of opiate maintenance therapies. European Neuropsychopharmacology, 16 (Suppl. 4), 503. doi:10.1016/S0924-977X(06)70684-8
Peer Reviewed verified by ORBi

Desseilles, M., Schwartz, S., Dang Vu, T. T., Sterpenich, V., Darsaud, A., Albouy, G., Vandewalle, G., Gais, S., Schabus, M., Rauchs, G., Degueldre, C., Luxen, A., Ansseau, M., & Maquet, P. (September 2006). Effects of attention and emotion on face processing in depression: a functional MRI study. The Journal of the European College of Neuropsychopharmacology, 16 (supplement 4), 271.
Peer reviewed

Lorant, V., Croux, C., Weich, S., Deliege, D., Mackenbach, J., & Ansseau, M. (September 2006). Depression and socio-economic status: an 8-year longitudinal population-based study. European Neuropsychopharmacology, 16 (Suppl. 4), 294-S295. doi:10.1016/S0924-977X(06)70301-7
Peer Reviewed verified by ORBi

Linotte, S., Barreto, M., Van Geit, N., D'haenen, H., Vanderkelen, P., Schepers, N., Scantamburlo, G., Pitchot, W., Ansseau, M., Van der Auwera, K., Bollen, J., Souery, D., & Mendlewicz, J. (September 2006). Clinical characteristics of depressive episodes in Bipolar I and Bipolar II disorders. European Neuropsychopharmacology, 16 (Suppl. 4), 301. doi:10.1016/S0924-977X(06)70314-5
Peer Reviewed verified by ORBi

Desseilles, M., Schwartz, S., Dang-Vu, T. T., Sterpenich, V., Darsaud, A., Albouy, G., Vandewalle, G., Gais, S., Schabus, M., Rauchs, G., Degueldre, C., Luxen, A., Ansseau, M., & Maquet, P. (September 2006). Effects of attention and emotion on face processing in depression: a functional MRI study. European Neuropsychopharmacology, 16 (Suppl. 4), 271. doi:10.1016/S0924-977X(06)70257-7
Peer Reviewed verified by ORBi

David, H. N., Ansseau, M., Lemaire, M., & Abraini, J. H. (01 July 2006). Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization. Biological Psychiatry, 60 (1), 49-57. doi:10.1016/j.biopsych.2005.10.007
Peer Reviewed verified by ORBi

Laloyaux, O., Ansseau, M., & Hansenne, M. (2006). Impact of low-frequency transcranial magnetic stimulation on brain automatic information processing - A mismatch negativity study. Journal of Psychophysiology, 20 (4), 267-275. doi:10.1027/0269-8803.20.4.267
Peer reviewed

Desseilles, M., Fuchs, S., Ansseau, M., Lopez, S., Vinckenbosh, E., & Andreoli, A. (2006). Achalasia may mimic anorexia nervosa, compulsive eating disorder, and obesity problems. Psychosomatics, 47 (3), 270-1. doi:10.1176/appi.psy.47.3.270
Peer Reviewed verified by ORBi

Reggers, J., SOMERS, L., Richy, F., VAN DEUN, P., SABBE, B., & Ansseau, M. (Eds.). (2006). Intérêt des traitements de substitution dans la dépendance aux opiacés. Gent, Belgium: Academia Press.

Ansseau, M. (2006). Le temps de l'anxiété. Tempo Médical, 279, 19-20.
Peer reviewed

De Grégorio, F., Damsa, C., Adam, E., Reggers, J., Lazignac, C., & Ansseau, M. (2006). L'utilisation du système de santé avant un passage à l'acte suicidaire : étude préliminaire dans un service d'urgences psychiatriques. Annales Médico-Psychologiques, 164 (7), 574-580. doi:10.1016/j.amp.2006.06.006
Peer Reviewed verified by ORBi

Desseilles, M., Maquet, P., Sterpenich, V., Vandewalle, G., Peters, F., Darsaud, A., Degueldre, C., Luxen, A., Ansseau, M., & Schwartz, S. (2006). Effects of attention on emotional face processing in depression : a functional MRI study [Poster presentation]. Highlights in Psychiatry, Bruxelles, Belgium.

Scantamburlo, G., Hansenne, M., Fuchs, S., PITCHOT, W., Reggers, J., ANSSEAU, M., & Legros, J.-J. (2006). OXYTOCIN, VASOPRESSIN AND ANXIETY IN MAJOR DEPRESSION: AGO-ANTAGONIST NEUROHROMONES. European Neuropsychopharmacology, 16, 306-S307.
Peer Reviewed verified by ORBi

Polis, M.-H., Pitchot, W., & Ansseau, M. (2006). Dépression et neuroplasticité : des découvertes neuroanatomiques aux nouvelles stratégies thérapeutiques. Acta Psychiatrica Belgica, 106 (1), 20-31.
Peer Reviewed verified by ORBi

Ansseau, M., Dierick, M., Buntinx, F., Cnockaert, P., De Smedt, J., Van Den Haute, M., & Vander Mijnsbrugge, D. (2006). Hoge prevalentie van mentale stoornissen in de eerste lijn. Resultaten van een cross-sectioneel onderzoek. Huisarts Nu, 35, 499-505.

Pitchot, W., & Ansseau, M. (2006). Rôle des récepteurs 5-HT1A dans le comportement suicidaire. Neurone, 11, 90-94.

Ansseau, M. (2006). Utilité des antidépresseurs dans les troubles anxieux. Revue Médicale Suisse, 2 (76), 1885-1891.
Peer Reviewed verified by ORBi

David, H. N., Ansseau, M., & Abraini, J. H. (15 December 2005). Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals. Brain Research Reviews, 50 (2), 336-360. doi:10.1016/j.brainresrev.2005.09.002
Peer Reviewed verified by ORBi

Reggers, J., Somers, L., Richy, F., Van Deun, P., Sabbe, B., & Ansseau, M. (2005). Efficacité et efficience des molécules substitutives dans le traitement de la dépendance aux opiacés. (DR/17). Belgium: Service de Programmation Fédérale – Politique Scientifique Fédérale.

Scantamburlo, G., Fuchs, S., Pitchot, W., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2005). Plasma oxytocin and anxiety in depressed patients. European Neuropsychopharmacology, 15 (Suppl. 3), 430.
Peer Reviewed verified by ORBi

Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2005). AVP- and OT-neurophysins response to apomorphine and clonidine in major depression. Psychoneuroendocrinology, 30 (9), 839-845. doi:10.1016/j.psyneuen.2005.04.015
Peer Reviewed verified by ORBi

Ansseau, M., Fischler, B., Dierick, M., Mignon, A., & Leyman, S. (May 2005). Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: the GADIS study. European Psychiatry, 20 (3), 229-235. doi:10.1016/j.eurpsy.2004.09.035
Peer Reviewed verified by ORBi

Scantamburlo, G., Ansseau, M., & Legros, J.-J. (March 2005). Neurophysins response to apomorphine and clonidine in major depression. European Neuropsychopharmacology, 15 (Suppl. 1), 77-S78. doi:10.1016/S0924-977X(05)80201-9
Peer Reviewed verified by ORBi

Ansseau, M. (February 2005). Critères prédictifs de l'évolution d'un accès maniaque. Encéphale (L'), 31 (Pt 2), 38-41.
Peer Reviewed verified by ORBi

Ansseau, M. (2005). La dépression : les vérités tout terrain (1/3). Tempo Médical, (272), 57-58.
Peer reviewed

Ansseau, M. (2005). Evaluatie van de activiteit van capsules droogextract van passiebloem, volgens een "ster"-model. Farmaceutisch Tijdschrift voor Belgie, (2), 11-14.
Peer reviewed

Ansseau, M. (2005). La dépression : au cœur du mal (2/3). Tempo Médical, 272, 57-58.
Peer reviewed

Ansseau, M. (2005). Obsessive-compulsive personality disorder: Response to pharmacological treatment. In M. Maj, H. S. Akiskal, J. E. Mezzich, ... A. Okasha (Eds.), Personality Disorders (pp. 468-471). Chichester, United Kingdom: Wiley & Sons, Ltd.

Guillon, M. S., Crocq, M. A., Bartholomé, F., Macher, J. P., & Ansseau, M. (2005). Estime de soi et troubles psychiatriques à l'adolescence. Acta Psychiatrica Belgica, 105 (2), 103-109.
Peer Reviewed verified by ORBi

Ansseau, M. (2005). La dépression : la réponse thérapeutique (3/3). Tempo Médical, 274, 109-110.
Peer reviewed

ANSSEAU, M. (2005). Obsessive-compulsive personality disorder: Response to pharmacological treatment. In M. Maj, Personality disorders (pp. 468-471). Chichester, United Kingdom: John Wiley & Sons, Ltd. doi:10.1002/0470090383.ch6

Ansseau, M. (2005). Actualités autour des troubles affectifs. Tempo Médical, (274), 24-25.
Peer reviewed

Ansseau, M., Gustin, F., Hodiaumont, F., Lemaître, A., Lo Bue, S., Lorant, V., Portet, M.-I., Reggers, J., Tyberghein, M., & Van Deun, P. (2005). DHCo Délivrance d'héroïne sous contrôle médical. Gand, Belgium: Academia Press.

Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2005). 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. Biological Psychiatry, 58 (11), 854-8. doi:10.1016/j.biopsych.2005.05.042
Peer Reviewed verified by ORBi

Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2004). Neurohypophyseal response to apomorphine and clonidine stimulation in major depression. European Neuropsychopharmacology, 14 (Suppl. 3), 291-S292. doi:10.1016/S0924-977X(04)80355-9
Peer Reviewed verified by ORBi

Reggers, J., Ansseau, M., Gustin, F., Pirard, S., van Deun, P., Seghers, A., Earley, P., Besson, J., & Gastfriend, D. (October 2004). Adaptation and validation of the ASAM PPC-2R criteria in French and Dutch speaking Belgian drug-addicts. European Neuropsychopharmacology, 14 (Suppl. 3), 354-S355.
Peer Reviewed verified by ORBi

Fuchs, S., Reggers, J., Pinto, E., Scantamburlo, G., Pitchot, W., Hansenne, M., Maertens De Noordhout, A., & Ansseau, M. (October 2004). Therapeutic application of right prefrontal low repetitive transcranial magnetic stimulation on depressed patients. European Neuropsychopharmacology, 14 (Suppl. 3), 226. doi:10.1016/S0924-977X(04)80206-2

Ansseau, M., Demyttenaere, K., Heyrman, J., Migeotte, A., Leyman, S., & Mignon, A. (June 2004). OREON: Observation of remission in depression in primary and psychiatric care. International Journal of Neuropsychopharmacology, 7 (Suppl. 1), 167.
Peer Reviewed verified by ORBi

Pinto, E., & Ansseau, M. (May 2004). Les alcoolisations paroxystiques. Revue Médicale de Liège, 59 (5), 297-300.

Scantamburlo, G., & Ansseau, M. (May 2004). L'attaque de panique. Revue Médicale de Liège, 59 (5), 293-6.
Peer reviewed

Pitchot, W., Wauthy, J., Legros, J.-J., & Ansseau, M. (March 2004). Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study. European Neuropsychopharmacology, 14 (2), 151-155. doi:10.1016/S0924-977X(03)00108-1
Peer Reviewed verified by ORBi

Crasson, M., Kjiri, S., Colin, A., Kjiri, K., L'Hermitte-Balériaux, M., Ansseau, M., & Legros, J.-J. (2004). Serum melatonin and urinary 6-sulfatoxymelatonin in major depression. Psychoneuroendocrinology, 29, 1-12. doi:10.1016/S0306-4530(02)00123-3
Peer Reviewed verified by ORBi

Le Bon, O., Basiaux, P., Streel, E., Tecco, J., Hanak, C., Hansenne, M., Ansseau, M., Pelc, I., Verbanck, P., & Dupont, S. (2004). Personality profile and drug of choice; a multivariate analysis using Cloninger's TCI on heroin addicts, alcoholics, and a random population group. Drug and Alcohol Dependence, 73 (2), 175-82. doi:10.1016/j.drugalcdep.2003.10.006
Peer Reviewed verified by ORBi

Hansenne, M., Laloyaux, O., Mardaga, S., & Ansseau, M. (2004). Impact of low frequency transcranial magnetic stimulation on event-related brain potentials. Biological Psychology, 67 (3), 331-41. doi:10.1016/j.biopsycho.2004.01.004
Peer Reviewed verified by ORBi

Masson, A.-M., Hoyois, P., Cadot, M., Nahama, V., Petit, F., & ANSSEAU, M. (2004). Les filles réussissent mieux que les garçons a l'université: Étude et modélisation des facteurs relatifs à la motivation et à l'agressivité mis en jeu lors des épreuves. Encéphale (L'), 30 (1), 1-15. doi:10.1016/s0013-7006(04)95410-3
Peer Reviewed verified by ORBi

Ansseau, M. (2004). Evaluation des paramètres d'activité de gélules d'extrait sec de passiflore selon un modele "en étoile". Journal de Pharmacie de Belgique, 59 (4), 97-99.
Peer Reviewed verified by ORBi

Ansseau, M., Dierick, M., Buntinkx, F., Cnockaert, P., De Smedt, J., Van Den Haute, M., & Vander Mijnsbrugge, D. (2004). High prevalence of mental disorders in primary care. Journal of Affective Disorders, 78 (1), 49-55. doi:10.1016/s0165-0327(02)00219-7
Peer Reviewed verified by ORBi

Charlier, C., Broly, F., Pinto, E., Ansseau, M., Plomteux, G., & Lhermitte, M. (December 2003). Polymorphisms in the CYP 2D6 gene: Association with plasma concentrations of fluoxetine and paroxetine. Therapeutic Drug Monitoring, 25 (6), 738-742. doi:10.1097/00007691-200312000-00014
Peer Reviewed verified by ORBi

Tortolani, I., Scantamburlo, G., Ansseau, M., & Legros, J.-J. (October 2003). Exposition hormonale precoce et repercussions comportementales dans l'hyperplasie congenitale des surrenales: a propos d'un cas. Revue Médicale de Liège, 58 (10), 631-4.
Peer reviewed

Papart, P., Liota, F., Bartholomé, F., & Ansseau, M. (September 2003). Cognitive topography imbalance in alcoholism. Journal of Psychophysiology, 17 (Suppl 1), 7-8.
Peer reviewed

Mignon, A., Fischler, B., Ansseau, M., Dierick, M., & Leyman, S. (September 2003). Generalized anxiety and major depression in a Belgian primary care setting, influence by socio-economic factors. The GADIS II study. European Neuropsychopharmacology, 13 (Suppl. 4), 368.
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Hansenne, M., Pitchot, W., Fuchs, S., Gorwood, P., Vaira, D., & Ansseau, M. (September 2003). Relationships between DRD2 and DAT polymorphisms and personality traits in healthy subjects. European Neuropsychopharmacology, 13 (Suppl. 4), 427-S428. doi:10.1016/S0924-977X(03)92300-5
Peer Reviewed verified by ORBi

De Witte, P., Pinto, E., Ansseau, M., & Verbanck, P. (May 2003). Alcohol and withdrawal: from animal research to clinical issues. Neuroscience and Biobehavioral Reviews, 27 (3), 189-197. doi:10.1016/S0149-7634(03)00030-7
Peer Reviewed verified by ORBi

Lorant, V., Deliege, D., Eaton, W., Robert, A., Philippot, P., & Ansseau, M. (15 January 2003). Socioeconomic inequalities in depression: A meta-analysis [letter to the editor]. American Journal of Epidemiology, 157 (2), 98-112. doi:10.1093/aje/kwf182
Peer Reviewed verified by ORBi

Hansenne, M., Pinto, E., Scantamburlo, G., Renard, B., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Harm avoidance is related to mismatch negativity (MMN) amplitude in healthy subjects. Personality and Individual Differences, 34 (6), 1039-1048. doi:10.1016/S0191-8869(02)00088-0
Peer Reviewed verified by ORBi

Pitchot, W., Reggers, J., Pinto, E., Hansenne, M., & Ansseau, M. (2003). Catecholamine and HPA axis dysfunction in depression : relationship with suicidal behavior. Neuropsychobiology, 47 (3), 152-157. doi:10.1159/000070585
Peer Reviewed verified by ORBi

Lorant, V., Kampfl, D., Seghers, A., Deliege, D., Closon, M. C., & Ansseau, M. (2003). Socio-economic differences in psychiatric in-patient care. Acta Psychiatrica Scandinavica, 107 (3), 170-177. doi:10.1034/j.1600-0447.2003.00071.x
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Fuchs, S., Venneman, I., Lamy, M., & Ansseau, M. (2003). Toxicomanes: sevrage ultrarapide aux opiacés sous anesthésie générale au CHU de Liège. Agenda Psychiatrie, 28, 1-2.
Peer reviewed

Colin, A., Reggers, J., Castronovo, V., & Ansseau, M. (2003). Lipides, dépression et suicide. Encéphale (L'), 29 (1, JAN-FEB), 49-58.
Peer Reviewed verified by ORBi

Hansenne, M., Olin, C., Pinto, E., Pitchot, W., & Ansseau, M. (2003). Event-related potentials to emotional and neutral stimuli in alcoholism. Neuropsychobiology, 48 (2), 77-81. doi:10.1159/000072881
Peer Reviewed verified by ORBi

Couvreur, A., Cleinge, L., Wauthy, J., Vaulet, V., Meeremans, C., Tacconi, G., Debaere, T., Ansseau, M., & Pitchot, W. (2003). Le fonctionnement en réseau : une nouvelle vision de soins en santé mentale. Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles, (5), 59-67.
Peer reviewed

Masson, A.-M., Cadot, M., & Ansseau, M. (2003). Perfectionnisme: Effets du sexe et de l'echec. Encéphale (L'), 29 (2), 125-135.
Peer Reviewed verified by ORBi

PAQUAY, C., PITCHOT, W., Reggers, J., & ANSSEAU, M. (2003). Dépression, anxiété, agressivité, impulsivité et comportement suicidaire. Acta Psychiatrica Belgica, 103, 161-170.
Peer Reviewed verified by ORBi

Hansenne, M., Pinto, E., Scantamburlo, G., Couvreur, A., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Mismatch negativity is not correlated with neuroendocrine indicators of catecholaminergic activity in healthy subjects. Human Psychopharmacology, 18 (3), 201-5. doi:10.1002/hup.468
Peer Reviewed verified by ORBi

Charlier, C., Pinto, E., Ansseau, M., & Plomteux, G. (December 2002). Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients. Journal of Psychopharmacology, 16 (4), 369-372. doi:10.1177/026988110201600413
Peer Reviewed verified by ORBi

Pitchot, W., Wauthy, J., Hansenne, M., Pinto, E., Fuchs, S., Reggers, J., Legros, J.-J., & Ansseau, M. (October 2002). Hormonal and temperature responses to the 5-HT1a receptor agonist flesinoxan in normal volunteers. Psychopharmacology, 164 (1), 27-32. doi:10.1007/s00213-002-1177-0
Peer Reviewed verified by ORBi

Michel, A., Ansseau, M., Legros, J.-J., Pitchot, W., & Mormont, C. (October 2002). The transsexual : what about the future ? European Psychiatry, 17 (6), 353-362. doi:10.1016/S0924-9338(02)00703-4
Peer Reviewed verified by ORBi

Dierick, M., De Nayer, A., Ansseau, M., D'Haenen, H., Cosyns, P., Verbruggen, W., Seghers, A., Pelc, I., Fossion, P., Stefos, G., Peuskens, J., Malfroid, M., Leyman, S., & Mignon, A. (August 2002). An eight-week, open-label, uncontrolled, multicenter, phase IV study of remission rates in outpatients and inpatients with major depression treated with venlafaxine. Current Therapeutic Research, 63 (8), 475-485. doi:10.1016/s0011-393x(02)80053-4
Peer Reviewed verified by ORBi

Michel, A., Ansseau, M., Legros, J.-J., Pitchot, W., Cornet, J.-P., & Mormont, C. (August 2002). Comparisons of two groups of sex-change applicants based on the MMPI. Psychological Reports, 91 (1), 233-240. doi:10.2466/pr0.2002.91.1.233
Peer Reviewed verified by ORBi

Scantamburlo, G., Fuchs, S., Lancellotti, P., & Ansseau, M. (May 2002). Troubles anxieux et pathologies organiques: un diagnostic differentiel difficile. Revue Médicale de Liège, 57 (5), 303-306.
Peer reviewed

Kebers, F., Janvier, S., Colin, A., Legros, J.-J., & Ansseau, M. (2002). En quoi le syndrome de Klinefelter peut-il interesser le psychiatre et le pedopsychiatre? Encéphale (L'), 28 (3), 260-265.
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., & Ansseau, M. (2002). Serotonin, personality and borderline personality disorder. Acta Neuropsychiatrica, 14 (2), 66-70. doi:10.1034/j.1601-5215.2002.140203.x
Peer Reviewed verified by ORBi

Hansenne, M., Pinto, E., Pitchot, W., Reggers, J., Scantamburlo, G., Moor, M., & Ansseau, M. (2002). Further evidence on the relationship between dopamine and novelty seeking: a neuroendocrine study. Personality and Individual Differences, 33 (6), 967-977. doi:10.1016/S0191-8869(01)00205-7
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Scantamburlo, G., Fuchs, S., Pirard, S., & Ansseau, M. (2002). 5-HT1A dysfunction in borderline personality disorder. Psychological Medicine, 32 (5), 935-41. doi:10.1017/S0033291702005445
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., PITCHOT, W., Hansenne, M., Fuchs, S., & Ansseau, M. (2002). Neuroendocrine evaluation of 5-HT1A function in male alcoholic patients. Psychoneuroendocrinology, 27 (7), 873-879. doi:10.1016/S0306-4530(01)00088-9
Peer Reviewed verified by ORBi

ANSSEAU, M. (2002). Serotonergic Antidepressants in Obsessive-Compulsive Personality Disorder. In M. Maj, Obsessive-Compulsive Disorder (Second Edition) (pp. 89-91). Chichester, United States - New Jersey: Wiley Blackwell. doi:10.1002/0470861657.ch2
Peer reviewed

Triffaux, J.-M., Wauthy, J., Albert, A., Bertrand, J.-M., Limet, R., Demoulin, J.-C., Dozot, J.-P., & Ansseau, M. (December 2001). Psychological distress of surgical patients after orthotopic heart transplantation. Transplant International, 14 (6), 391-395. doi:10.1007/s001470100004
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., & Ansseau, M. (November 2001). Role of dopamine in non-depressed patients with a history of suicide attempts. European Psychiatry, 16 (7), 424-427. doi:10.1016/S0924-9338(01)00601-0
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., Pinto, E., Reggers, J., Fuchs, S., Pirard, S., & Ansseau, M. (October 2001). Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality. Psychoneuroendocrinology, 26 (7), 689-696. doi:10.1016/S0306-4530(01)00021-X
Peer Reviewed verified by ORBi

PITCHOT, W., Reggers, J., Pinto, E., Hansenne, M., Fuchs, S., Pirard, S., & Ansseau, M. (April 2001). Reduced dopaminergic activity in depressed suicides. Psychoneuroendocrinology, 26 (3), 331-335. doi:10.1016/S0306-4530(00)00047-0
Peer Reviewed verified by ORBi

Triffaux, J.-M., Wauthy, J., Bertrand, J.-M., Limet, R., Albert, A., & Ansseau, M. (April 2001). Psychological Evolution and Assessment in Patients Undergoing Orthotopic Heart Transplantation. European Psychiatry, 16 (3), 180-5. doi:10.1016/S0924-9338(01)00561-2
Peer Reviewed verified by ORBi

PITCHOT, W., & ANSSEAU, M. (2001). Venlafaxine induced hair loss. American Journal of Psychiatry. doi:10.1176/appi.ajp.158.7.1159-a
Peer Reviewed verified by ORBi

Hansenne, M., Le Bon, O., Gauthier, A., & Ansseau, M. (2001). Belgian normative data of the temperament and character inventory. European Journal of Psychological Assessment, 17 (1), 56-62. doi:10.1027//1015-5759.17.1.56
Peer reviewed

Scantamburlo, G., Ansseau, M., & Legros, J.-J. (2001). Implication de la neurohypophyse dans le stress psychique. Encéphale (L'), 27 (3, May-Jun), 245-59.
Peer Reviewed verified by ORBi

Mormont, C., & ANSSEAU, M. (2001). Anorexie. In M. Crahay & C. Goffinet (Eds.), Regards croisés sur l’anorexie (pp. 11-14). Liège, Belgium: ULg - Université de Liège.

PITCHOT, W., & ANSSEAU, M. (2001). Adding olanzapine to venlafaxine in treatment-refractory non-psychotic chronic depression. American Journal of Psychiatry.
Peer Reviewed verified by ORBi

Allouch, A., Bruwier, M., Comte-Tassin, M., ANDRIANNE, R., Colin, A., Kjiri, K., Reginster, J.-Y., de Leval, L., Ansseau, M., & Legros, J.-J. (2001). Incidence des perturbations psychoendocriniennes au centre interdisciplinaire de l’andropause (CIA) du CHU de Liège : bilan des 7 premiers mois d’activité. Annales d'Endocrinologie, 62 (4), 178.
Peer Reviewed verified by ORBi

David, C., WAUTHY, J., Vaulet, V., Frognet, E., Franck, N., PITCHOT, W., & ANSSEAU, M. (2001). Le médicament parmi les thérapies relationnelles : Enquête et réflexions. Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles.
Peer reviewed

Masson, A.-M., Cadot, M., Pereira, A. M., Depreeuw, E., & Ansseau, M. (2001). Version francophone du TASTE (test for ability to study and evaluation). Encéphale (L'), 27 (6), 527-538.
Peer Reviewed verified by ORBi

Lepine, J. P., Altamura, C., ANSSEAU, M., Ayuso Gutierrez, J. L., Bitter, I., Lader, M., & Waintraub, L. (2001). Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: An international, 6-week double-blind study. Human Psychopharmacology, 16 (3), 219-227. doi:10.1002/hup.289
Peer Reviewed verified by ORBi

Mancuso, G., Lejeune, M., & Ansseau, M. (2001). Cigarette Smoking and Attention: Processing Speed or Specific Effects? Psychopharmacology, 155 (4), 372-378. doi:10.1007/s002130000678
Peer Reviewed verified by ORBi

Hansenne, M., & Ansseau, M. (2001). Contingent negative variation and personality in depression. Neuropsychobiology, 44 (1), 7-12. doi:10.1159/000054907
Peer Reviewed verified by ORBi

PITCHOT, W., & ANSSEAU, M. (2001). Reply to Letter to the Editor. Psychoneuroendocrinology.
Peer Reviewed verified by ORBi

Lôo, H., Saiz-Ruiz, J., Costa E Silva, J. A., ANSSEAU, M., Herrington, R., Vaz-Serra, A., Dilling, H., & De Risio, S. (2001). Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. Human Psychopharmacology, 16 (Suppl. 1), 31-S38. doi:10.1002/hup.268
Peer Reviewed verified by ORBi

Guelfi, J. D., ANSSEAU, M., Timmerman, L., Kørsgaard, S., & The Mirtazapine-Venlafaxine Study Group. (2001). Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features. Journal of Clinical Psychopharmacology, 21 (4), 425-431. doi:10.1097/00004714-200108000-00010
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Delhez, M., Fuchs, S., Venneman, I., Lamy, M., & Ansseau, M. (2001). Le sevrage ultra-rapide des toxicomanes aux opiaces sous anesthésie générale: resultats préliminaires du protocole liégeois. Revue Médicale de Liège, 56 (8), 572-576.
Peer reviewed

Pinto, E., Reggers, J., Delhez, M., Fuchs, S., VENNEMAN, I., Lamy, M., & ANSSEAU, M. (2001). Le sevrage ultra-rapide des toxicomanes aux opiaciés sous anesthiésie géniérale: Résultats préliminaires du protocole Liègeois. Revue Médicale de Liège, 56 (8), 572-576.
Peer reviewed

Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2001). Alpha-2-adrenoreceptors in depressed suicide attempters : relationship with medical lethality of the attempt. Neuropsychobiology, 44 (2), 91-94. doi:10.1159/000054923
Peer Reviewed verified by ORBi

Pitchot, W., Herrera, C., & Ansseau, M. (2001). Hpa Axis Dysfunction in Major Depression: Relationship to 5-Ht(1a) Receptor Activity. Neuropsychobiology, 44 (2), 74-7. doi:10.1159/000054919
Peer Reviewed verified by ORBi

Dalem, I., Piccinin, B., Lerminiaux, D., & Ansseau, M. (December 2000). L'anorexie mentale du garcon. Revue Médicale de Liège, 55 (12), 1051-1057.
Peer reviewed

Charlier, C., Pinto, E., Ansseau, M., & Plomteux, G. (August 2000). Relationship between Clinical Effects, Serum Drug Concentration, and Concurrent Drug Interactions in Depressed Patients Treated with Citalopram, Fluoxetine, Clomipramine, Paroxetine or Venlafaxine. Human Psychopharmacology, 15 (6), 453-459. doi:10.1002/1099-1077(200008)15:6<453::AID-HUP228>3.0.CO;2-F
Peer Reviewed verified by ORBi

Dandrifosse, A. C., & Ansseau, M. (May 2000). Recommandations dans le traitement des troubles anxieux chez l'adulte. Revue Médicale de Liège, 55 (5), 400-408.
Peer reviewed

Reggers, J., & Ansseau, M. (May 2000). Recommandations dans le traitement des toxicomanies aux opiacés. Revue Médicale de Liège, 55 (5), 409-416.
Peer reviewed

Fuchs, S., Reggers, J., & Ansseau, M. (May 2000). Recommandations dans le traitement de la dépression. Revue Médicale de Liège, 55 (5), 389-394.
Peer reviewed

Ansseau, M., Besson, J., Lejoyeux, M., Pinto, E., Landry, U., Cornes, M., Deckers, F., Potgieter, A., & Ades, J. (2000). A French translation of the obsessive-compulsive drinking scale for craving in alcohol-dependent patients: A validation study in Belgium, France, and Switzerland. European Addiction Research, 6 (2), 51-6. doi:10.1159/000019010
Peer Reviewed verified by ORBi

Ajamieh, A., & Ansseau, M. (2000). Les marqueurs biologiques dans les personnalites schizotypique et borderline. Encéphale (L'), 26 (6), 42-54.
Peer Reviewed verified by ORBi

Triffaux, J.-M., Wauthy, J., Albert, A., Bertrand, J., Limet, R., demoulin, J.-C., dozot, J.-P., & Ansseau, M. (2000). Effect of psychological intervention on psychopathology after heart transplantation [Poster presentation]. XXII C.I.N.P Congres, Bruxelles, Belgium.

Hansenne, M., Pitchot, W., Pinto, E., Papart, P., & Ansseau, M. (2000). Serotonergic-1a activity and contingent negative variation. Biological Psychology, 52 (3), 259-65. doi:10.1016/S0301-0511(99)00047-2
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Papart, P., & Ansseau, M. (2000). P300 event-related brain potential and personality in depression. European Psychiatry, 15 (6), 370-7. doi:10.1016/S0924-9338(00)00505-8
Peer Reviewed verified by ORBi

Papart, P., WEERTS, P., Pinto, E., Hansenne, M., & Ansseau, M. (2000). Relationship between CNV topography and irritability in depression. Journal of Psychophysiology, 14 (Suppl 1).
Peer reviewed

Calvisi, V., & Ansseau, M. (December 1999). Le cas clinique du mois. Confusion mentale liée à l'administration de tramadol chez une patiente sous IMAO. Revue Médicale de Liège, 54 (12), 912-913.
Peer reviewed

Coton, X., Ansseau, M., Parent, M.-T., Jadot, M., & Ernotte, D. (September 1999). Un cas de myasthenie diagnostiquee trouble de conversion. Revue Médicale de Liège, 54 (9), 722-724.
Peer reviewed

Ansseau, M. (August 1999). Pharma-clinics. Le medicament du mois. Le zaleplon (Sonataρ). Revue Médicale de Liège, 54 (8), 705-6.
Peer reviewed

Reggers, J., & Ansseau, M. (April 1999). Les phobies spécifiques chez la femme. Revue Médicale de Liège, 54 (4), 329-334.
Peer reviewed

Vanturenhout, C., & Ansseau, M. (April 1999). La dépression chez la femme. Revue Médicale de Liège, 54 (4), 322-328.
Peer reviewed

Hansenne, M., & Ansseau, M. (1999). P300 event-related potential and serotonin-1A activity in depression. European Psychiatry, 14 (3), 143-7. doi:10.1016/S0924-9338(99)80732-9
Peer Reviewed verified by ORBi

Hansenne, M., & Ansseau, M. (1999). Harm avoidance and serotonin. Biological Psychology, 51 (1), 77-81. doi:10.1016/S0301-0511(99)00018-6
Peer Reviewed verified by ORBi

Charlier, C., Ansseau, M., Pinto, E., Andrien, F., & Plomteux, G. (1999). Le controle thérapeutique des médicaments antidépresseurs. Annales de Biologie Clinique, 57 (4, Jul-Aug), 463-8.
Peer Reviewed verified by ORBi

Mancuso, G., Andrès Bénito, P., Ansseau, M., & Tirelli, E. (1999). Effects on nicotine administered via a transdermal delivery system on vigilance : a repeated measure study. Psychopharmacology, 142 (1), 18-23. doi:10.1007/s002130050857
Peer Reviewed verified by ORBi

Reginster, J.-Y., Deroisy, R., Paul, I., Hansenne, M., & Ansseau, M. (1999). Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women. Maturitas, 33 (2), 133-7. doi:10.1016/S0378-5122(99)00057-2
Peer Reviewed verified by ORBi

Lôo, H., Saiz-Ruiz, J., Costa E Silva, J. A., ANSSEAU, M., Herrington, R., Vaz-Serra, A., Dilling, H., & De Risio, S. (1999). Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. Journal of Affective Disorders, 56 (2-3), 109-118. doi:10.1016/S0165-0327(99)00009-9
Peer Reviewed verified by ORBi

Coton, X., ANSSEAU, M., Parent, M., Jadot, M., & Ernotte, D. (1999). Le cas clinique du mois un cas de myasthénie diagnostiquée trouble de conversion. Revue Médicale de Liège, 54 (9), 722-724.
Peer reviewed

Hansenne, M., Reggers, J., Pinto, E., Kjiri, K., Ajamier, A., & Ansseau, M. (1999). Temperament and character inventory (TCI) and depression. Journal of Psychiatric Research, 33 (1), 31-6. doi:10.1016/S0022-3956(98)00036-3
Peer Reviewed verified by ORBi

Ansseau, M. (May 1998). Socio-économie de la dépression. Revue Médicale de Liège, 53 (5), 308-310.
Peer reviewed

Ansseau, M. (February 1998). Pharma-clinics. Le médicament du mois. La venlafaxine (Efexor). Revue Médicale de Liège, 53 (2), 106-108.
Peer reviewed

Kjiri, K., Ajamieh, A., Hansenne, M., & ANSSEAU, M. (1998). Un cas de syndrome de Munchausen (trouble factice). Revue Médicale de Liège, 53 (7), 390-392.
Peer reviewed

Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Machurot, P. Y., & Ansseau, M. (1998). The tridimensional personality questionnaire (TPQ) and depression. European Psychiatry, 13 (2), 101-3. doi:10.1016/S0924-9338(98)80026-6
Peer Reviewed verified by ORBi

Hansenne, M., & Ansseau, M. (1998). Catecholaminergic function and temperament in major depressive disorder: a negative report. Psychoneuroendocrinology, 23 (5), 477-83. doi:10.1016/S0306-4530(98)00021-3
Peer Reviewed verified by ORBi

ANSSEAU, M., & PITCHOT, W. (1998). Dépression et suicide : Aspects biologiques. Neuro-psy.
Peer reviewed

Guelfi, J. D., ANSSEAU, M., Corruble, E., Samuelian, J. C., Tonelli, I., Tournoux, A., & Plétan, Y. (1998). A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients. International Clinical Psychopharmacology, 13 (3), 121-128. doi:10.1097/00004850-199805000-00005
Peer Reviewed verified by ORBi

Kjiri, K., Ajamieh, A., Hansenne, M., & Ansseau, M. (1998). Le cas clinique du mois. Un cas de syndrome de Munchausen (trouble factice). Revue Médicale de Liège, 53 (7), 390-2.
Peer reviewed

Abraini, J. H., ANSSEAU, M., Bisson, T., Juan De Mendoza, J.-L., & Therme, P. (1998). Personality patterns of anxiety during occupational deep dives with long-term confinement in hyperbaric chamber. Journal of Clinical Psychology, 54 (6), 825-830. doi:10.1002/(SICI)1097-4679(199810)54:6<825::AID-JCLP10>3.0.CO;2-N
Peer Reviewed verified by ORBi

Hansenne, M., PITCHOT, W., Papart, P., & ANSSEAU, M. (1998). Serotonergic modulation of the P300 event related brain potential. Human Psychopharmacology, 13 (4), 239-243. doi:10.1002/(SICI)1099-1077(199806)13:4<239::AID-HUP986>3.0.CO;2-V
Peer Reviewed verified by ORBi

Ansseau, M. (01 November 1997). Dépressions brèves récurrentes. Revue du Praticien, 47 (17), 1904-1906.
Peer reviewed

Charlier, C., Ansseau, M., Gougnard, T., Andrien, F., & Plomteux, G. (May 1997). Le monitoring thérapeutique des antidépresseurs. Revue Médicale de Liège, 52 (5), 336-44.
Peer reviewed

Ansseau, M. (April 1997). La dépression de la personne âgée. Revue Médicale de Liège, 52 (4), 262-266.
Peer reviewed

Charlier, C., Ansseau, M., Pinto, E., Andrien, F., & Plomteux, G. (1997). Manifestations indésirables des antidépresseurs. Toxicorama, (Spécial LYON), 310-314.
Peer reviewed

Hansenne, M., Pitchot, W., Moreno, A. G., Reggers, J., Machurot, P.-Y., & Ansseau, M. (1997). Harm avoidance dimension of the Tridimensional Personality Questionnaire and serotonin-1A activity in depressed patients. Biological Psychiatry, 42 (10), 959-61. doi:10.1016/S0006-3223(97)00325-9
Peer Reviewed verified by ORBi

Ramaekers, J. G., ANSSEAU, M., Muntjewerff, N. D., Sweens, J. P., & O'Hanlon, J. F. (1997). Considering the P450 cytochrome system as determining combined effects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients. International Clinical Psychopharmacology, 12 (3), 159-169. doi:10.1097/00004850-199705000-00007
Peer Reviewed verified by ORBi

Papart, P., Ansseau, M., & Timsit-Berthier, M. (1997). Influence of Diazepam on Contingent Negative Variation. Human Psychopharmacology, 12, 95-98. doi:10.1002/(SICI)1099-1077(199703/04)12:2<95::AID-HUP841>3.0.CO;2-3
Peer Reviewed verified by ORBi

Ansseau, M. (October 1996). Pharma-clinics. Le médicament du mois. La risperidone (Risperdal). Revue Médicale de Liège, 51 (10), 665-667.
Peer reviewed

ANSSEAU, M., Bataille, M., Briole, G., De Nayer, A., Fauchère, P. A., Ferrero, F., Mertens, C., Realini, R., Rombaut, P., Vereecken, A., Troisfontaines, B., & Van Moffaert, M. (1996). Controlled comparison of tianeptine, alprazolam and mianserin in the treatment of adjustment disorders with anxiety and depression. Human Psychopharmacology, 11 (4), 293-298. doi:10.1002/(SICI)1099-1077(199607)11:4<293::AID-HUP771>3.0.CO;2-Z
Peer Reviewed verified by ORBi

Papart, P., Ansseau, M., & Timsit-Berthier, M. (1996). CNV in mood disorders. In Recent advances in event-related brain potential research (pp. 897-900). Elsevier Science.
Peer reviewed

Pitchot, W., Hansenne, M., Moreno, A. G., & Ansseau, M. (1996). Growth hormone response to apomorphine in obsessive-compulsive disorder. Journal of Psychiatry and Neuroscience, 21 (5), 343-5.
Peer Reviewed verified by ORBi

Ansseau, M. (January 1996). Les antidépresseurs. Revue Médicale de Liège, 51 (1), 78-84.
Peer reviewed

Ansseau, M. (1996). Les benzodiazépines. Revue Médicale de Liège, 51 (1), 70-77.
Peer reviewed

Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Zaldua, I. U., & Ansseau, M. (1996). Suicidal behavior in depressive disorder: an event-related potential study. Biological Psychiatry, 40 (2), 116-22. doi:10.1016/0006-3223(95)00372-X
Peer Reviewed verified by ORBi

ANSSEAU, M. (1996). Pharma-clinics, le médicament du mois : La rispéridone (Risperdal®). Revue Médicale de Liège, 51 (10), 665-667.
Peer reviewed

Pitchot, W., & Ansseau, M. (November 1995). Le cas clinique du mois. Dépression majeure chez un patient diabétique. Revue Médicale de Liège, 50 (11), 451-452.
Peer reviewed

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). Effect of previous antidepressant therapy on the growth hormone response to apomorphine. Neuropsychobiology, 32 (1), 19-22. doi:10.1159/000119207
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). Growth hormone response to clonidine in nondepressed patients with a history of suicide attempts. Biological Psychiatry, 38 (3), 201-203. doi:10.1016/0006-3223(95)00147-9
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Papart, P., Timsit-Berthier, M., & Ansseau, M. (1995). Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroencephalography and Clinical Neurophysiology, 96 (2), 194-196. doi:10.1016/0168-5597(94)00317-8
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). The dexamethasone suppression test in violent suicide attempters with major depression. Biological Psychiatry, 37 (4), 273-274. doi:10.1016/0006-3223(94)00228-U
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Lembreghts, M., Hansenne, M., Wauthy, J., Reel, C., Jammaer, R., Papart, P., Sulon, J., & Legros, J.-J. (1995). The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry, 28 (Suppl. 2), 91-92. doi:10.1055/s-2007-979625
Peer Reviewed verified by ORBi

Urcelay-Zaldua, I., Hansenne, M., & Ansseau, M. (1995). Influence du risque suicidaire et du desespoir sur l'amplitude de l'onde P300 dans la depression majeure. Neurophysiologie Clinique, 25 (5), 291-296. doi:10.1016/0987-7053(96)80172-9
Peer Reviewed verified by ORBi

Pichot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). Growth hormone response to apomorphine in panic disorder: comparison with major depression and normal controls. European Archives of Psychiatry and Clinical Neuroscience, 245 (6), 306-308. doi:10.1007/BF02191872
Peer Reviewed verified by ORBi

Fontaine, P., & ANSSEAU, M. (1995). Aspects pharmaco-cliniques de la méthadone : Revue de la littérature sur son intérêt dans le traitement des toxicomanies. Encéphale (L'), 21 (3), 167-179.
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., Wauthy, J., & Ansseau, M. (1995). Bases biologiques du comportement suicidaire: approche neuroendocrinienne et psychophysiologique du role des catecholamines. Acta Psychiatrica Belgica, 95 (4-5), 210-233.
Peer Reviewed verified by ORBi

Charles, G., Hansenne, M., Ansseau, M., Pitchot, W., Machowski, R., Schittecatte, M., & Wilmotte, J. (1995). P300 in posttraumatic stress disorder. Neuropsychobiology, 32 (2), 72-74. doi:10.1159/000119216
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., & Hansenne, M. (1995). Responses to mCPP stimulation in depressed patients. American Journal of Psychiatry, 152 (12), 1834; author reply 1834-5. doi:10.1176/ajp.152.12.1834
Peer Reviewed verified by ORBi

Ansseau, M. (01 December 1994). Comment je traite... Un trouble de l'adaptation avec anxiété. Revue Médicale de Liège, 49 (12), 643-644.
Peer reviewed

Ansseau, M. (01 November 1994). Comment je traite...un premier épisode dépressif. Revue Médicale de Liège, 49 (11), 591-592.
Peer reviewed

Ansseau, M., Orban, P., Lecoq, A., De Nayer, A. R., Evrard, J.-L., Kremer, P., Devoitille, J.-M., Dierick, M., Mertens, C., Mesotten, F., Mirel, J., Troisfontaines, B., van Moffaert, M., & Vanbrabant, E. (June 1994). Controlled Comparison of Nefazodone and Amitriptyline in Major Depressive Inpatients. Psychopharmacology, 115 (1-2), 254-60. doi:10.1007/BF02244780
Peer Reviewed verified by ORBi

Ansseau, M., Papart, P., Troisfontaines, B., Bartholome, F., Bataille, M., Charles, G., Schittecatte, M., Darimont, P., Devoitille, J. M., & De Wilde, J. (February 1994). Controlled Comparison of Milnacipran and Fluoxetine in Major Depression. Psychopharmacology, 114 (1), 131-7. doi:10.1007/BF02245454
Peer Reviewed verified by ORBi

Lucchesi, L. M., Fernandes, M. H., Silva Junior, N., Yazigi, L., ANSSEAU, M., & Timsit-Berthier, M. (1994). Transcultural approach of depression. Comparative study of the diagnostic performance of the dexamethasone suppression test in Sao Paulo (Brazil) and Liege (Belgium). European Psychiatry, 9 (4), 195-200.
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., & Gonzalez Moreno, A. (1994). Anxiolytic activity of single doses of the 5-HT3 antagonist zacopride. European Neuropsychopharmacology, 4 (3), 355. doi:10.1016/0924-977X(94)90177-5
Peer Reviewed verified by ORBi

ANSSEAU, M. (1994). In memoriam Daniel Bobon. Revue Médicale de Liège, 49 (10), 531-533.
Peer reviewed

Petit, N., Delporte, J.-P., ANSSEAU, M., Albert, A., & Jeusette, F. (1994). Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital. Pharmacy World and Science, 16 (4), 181-186. doi:10.1007/BF01872866
Peer Reviewed verified by ORBi

Triffaux, J.-M., Bertrand, M., ANSSEAU, M., Limet, R., & Kulbertus, H. (1994). Evaluation et accompagnement psychologique au cours de la transplantation cardiaque. Psychologie Médicale, 26 (2), 175-179.
Peer reviewed

ANSSEAU, M. (1994). Depression, 5‐HT deficit, SSRIs…and tianeptine. Human Psychopharmacology, 9 (6), 391-392. doi:10.1002/hup.470090601
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Gonzalez Torrecilas, J., Mirel, J., & Ansseau, M. (1994). Psychophysiological correlates of suicidal behavior in depression. A preliminary study. Neuropsychobiology, 30 (1), 1-3. doi:10.1159/000119125
Peer Reviewed verified by ORBi

Triffaux, J.-M., Bertrand, J., Ansseau, M., Limet, R., & Kulbertus, H. (1994). Evaluation et accompagnement psychologique du patient au cours de la transplantation cardiaque. Psychologie Médicale, 26 (Spéc. 2), 175-179.
Peer reviewed

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Wauthy, J., Hansenne, M., & von Frenckell, R. (1994). Relationship between alpha 2-adrenergic function and suicidal behavior in depressed patients. Psychiatry Research, 52 (2), 115-123. doi:10.1016/0165-1781(94)90081-7
Peer Reviewed verified by ORBi

Ansseau, M., PITCHOT, W., Hansenne, M., WAUTHY, J., Moreno, A. G., Jammaer, R., Réel, C., Lembreghts, M., Papart, P., Gros-Gean, J., Devroye, A., Sulon, J., & Legros, J.-J. (1994). The flesinoxan/5-HT1A receptor challenge and suicidal behavior. European Neuropsychopharmacology, 4 (3), 322-323. doi:10.1016/0924-977X(94)90138-4
Peer Reviewed verified by ORBi

ANSSEAU, M. (1994). Are SSRIs useful in obsessive-compulsive personality disorder? European Neuropsychopharmacology, 4 (3), 266-267. doi:10.1016/0924-977X(94)90085-X
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Wauthy, J., Moreno, A. G., Hansenne, M., Lembreghts, M., Jammaer, R., Réel, C., Gros-Gean, J., Sulon, J., & Legros, J.-J. (1994). The flesinoxan/5-HT1A receptor challenge in major depression. European Neuropsychopharmacology, 4 (3), 321-322. doi:10.1016/0924-977X(94)90137-6
Peer Reviewed verified by ORBi

ANSSEAU, M. (1994). Placebo-controlled study of clomipramine in panic patients taking benzodiazepines. European Neuropsychopharmacology, 4 (3), 356. doi:10.1016/0924-977X(94)90178-3
Peer Reviewed verified by ORBi

WAUTHY, J., Mormont, C., & Ansseau, M. (1994). Troubles mnésiques et éléments de "psychopathologie" chez des patients déprimés majeurs. Acta Psychiatrica Belgica, 94 (1), 58-9.
Peer Reviewed verified by ORBi

Abraini, J. H., ANSSEAU, M., Martinez, E., Burner, H., Wauthy, J., & Lemaire, C. (1994). Development of anxiety symptoms during a deep diving experiment. Anxiety, 1 (5), 237-241. doi:10.1002/anxi.3070010509
Peer Reviewed verified by ORBi

ANSSEAU, M., Gabriëls, A., Loyens, J., Bartholomé, F., Evrard, J. L., De Nayer, A., Linhart, R., Wirtz, J., Bruynooghe, F., Surinx, K., Clarysse, H., Marganne, R., & Papart, P. (1994). Controlled comparison of paroxetine and fluvoxamine in major depression. Human Psychopharmacology, 9 (5), 329-336. doi:10.1002/hup.470090502
Peer Reviewed verified by ORBi

Schittecatte, M., Charles, G., Machowski, R., Dumont, F., Garcia-Valentin, J., Wilmotte, J., Papart, P., PITCHOT, W., WAUTHY, J., Ansseau, M., Pelc, I., & Hoffman, G. (1994). Effect of gender and diagnostic on growth hormone response to clonidine for major depression : A large scale multicenter study. American Journal of Psychiatry, 151 (2), 216-220. doi:10.1176/ajp.151.2.216
Peer Reviewed verified by ORBi

Papart, P., ANSSEAU, M., & Timsit-Berthier, M. (1994). Contingent negative variation (CNV) in mood disorders. European Neuropsychopharmacology, 4 (3), 323. doi:10.1016/0924-977x(94)90139-2
Peer Reviewed verified by ORBi

Abraini, J. H., Ansseau, M., & Fechtali, T. (01 November 1993). Pressure-Induced Disorders in Neurotransmission and Spontaneous Behavior in Rats: An Animal Model of Psychosis. Biological Psychiatry, 34 (9), 622-629. doi:10.1016/0006-3223(93)90154-6
Peer Reviewed verified by ORBi

Ansseau, M. (August 1993). Critères cliniques d'évaluation de la guérison de la dépression. Aspects méthodologiques. Encéphale (L'), 19 (Spec No 3), 441-4.
Peer Reviewed verified by ORBi

Angst, J., ANSSEAU, M., Bech, P., Engel, R. R., Hippius, H., Lader, M., Lecrubier, Y., Lingjaerde, O., Paes de Sousa, M., Rossi, A., Ruther, E., Saletu, B., Stefanis, C. N., Stoll, K. D., Westenberg, H. G. M., & Woggon, B. (1993). Report on the Fourth Consensus Conference on the Methodology of Clinical Trials with Anxiolytic Drugs. Pharmacopsychiatry, 26 (1), 1-5. doi:10.1055/s-2007-1014332
Peer Reviewed verified by ORBi

Hansenne, M., Charles, G., Pholien, P., Panzer, M., PITCHOT, W., & Ansseau, M. (1993). Mesure subjective de l'impact d'un événement : traduction française et adaptation de l'échelle d'Horowitz. Psychologie Médicale, 25 (1), 86-88.
Peer reviewed

Machurot, P.-Y., Hansenne, M., Pitchot, W., Gonzalez Moreno, A., & Ansseau, M. (1993). L'état de stress post-traumatique chez les brûlés : Une revue. Acta Psychiatrica Belgica, 93 Spec No, 359-367.
Peer Reviewed verified by ORBi

ANSSEAU, M., Leboulle, D., Sulon, J., von Frenckell, R., & Legros, J.-J. (1993). Oral contraceptives and the dexamethasone suppression test. Psychoneuroendocrinology, 18 (1), 37-43. doi:10.1016/0306-4530(93)90053-N
Peer Reviewed verified by ORBi

ANSSEAU, M., Gabriëls, A., Loyens, J., Bartholomé, F., Evrard, J.-L., De Nayer, A. R., Linhart, R., Wirtz, J., Bruynoghe, F., Surinx, K., Clarysse, H., Marganne, R., & Papart, P. (1993). A double-blind comparison of paroxetine and fluvoxamine in major depression. European Neuropsychopharmacology, 3 (3), 323-324. doi:10.1016/0924-977x(93)90099-8
Peer Reviewed verified by ORBi

Lembreghts, M., & Ansseau, M. (1993). Les marqueurs biologiques dans les schizophrénies. Encéphale (L'), 19 (5, Sep-Oct), 501-23.
Peer Reviewed verified by ORBi

Ansseau, M., & De Roeck, J. (1993). Trazodone in Benzodiazepine Dependence. Journal of Clinical Psychiatry, 54 (5), 189-191.
Peer Reviewed verified by ORBi

Hansenne, M., Charles, G., Pholien, P., Panzer, M., PITCHOT, W., Gonzalez Moreno, A., & ANSSEAU, M. (1993). Mesure subjective de l'impact d'un évènement : Traduction française et validation de l'échelle d’Horowitz. Psychologie Médicale, 25 (1), 86-88.
Peer reviewed

ANSSEAU, M., Jammaer, R., Réel, C., Wauthy, J., Lembreghts, M., PITCHOT, W., Moreno, A. G., Sulon, J., & Legros, J.-J. (1993). Effect of pindolol on the neuroendocrine and temperature responses to flesinoxan. European Neuropsychopharmacology, 3 (3), 368. doi:10.1016/0924-977X(93)90154-E
Peer Reviewed verified by ORBi

ANSSEAU, M. (1993). The paradox of tianeptine. European Psychiatry, 8 (SUPPL. 2), 89s-93.
Peer Reviewed verified by ORBi

ANSSEAU, M., Troisfontaines, B., Papart, P., & von Frenckell, R. (1993). Compulsive personality and serotonergic drugs. European Neuropsychopharmacology, 3 (3), 288-289. doi:10.1016/0924-977X(93)90077-Y
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Gonzalez Moreno, A., Papart, P., & WAUTHY, J. (1993). Pilot study of flesinoxan in major depression. Effect on REM latency and body temperature. Human Psychopharmacology, 8 (4), 279-283. doi:10.1002/hup.470080407
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Papart, P., Gonzalez Moreno, A., Timsit-Berthier, M., & LEGROS, J.-J. (1993). Intérêt des marqueurs biologiques de dépression dans le choix du traitement antidépressif. Médecine et Hygiène, 51 (1990), 1970-1976.
Peer Reviewed verified by ORBi

Legros, J.-J., ANSSEAU, M., & Timsit-Berthier, M. (1993). Neurohypophyseal peptides and psychiatric diseases. Regulatory Peptides, 45 (1-2), 133-138. doi:10.1016/0167-0115(93)90195-E
Peer Reviewed verified by ORBi

Pitchot, W., Gonzalez Moreno, A., Hansenne, M., Wauthy, J., & Ansseau, M. (1993). Role du systeme dopaminergique dans la depression: correlats cliniques du test a l'apomorphine. Acta Psychiatrica Belgica, 93 Spec No, 343-358.
Peer Reviewed verified by ORBi

ANSSEAU, M. (1992). Blunting of clonidine-stimulated growth hormone release in mania [19] [letter to the editor]. American Journal of Psychiatry, 149 (4), 584. doi:10.1176/ajp.149.4.584a
Peer Reviewed verified by ORBi

ANSSEAU, M., & De Roeck, J. (1992). Trazodone in benzodiazepine dependence. European Neuropsychopharmacology, 2 (3), 382. doi:10.1016/0924-977X(92)90237-3
Peer Reviewed verified by ORBi

ANSSEAU, M., Poncelet, P.-F., & Schmitz, D. (1992). High dose triazolam and anterograde amnesia [letter to the editor]. BMJ: British Medical Journal, 304 (6835), 1178. doi:10.1136/bmj.304.6835.1178-b
Peer Reviewed verified by ORBi

PITCHOT, W., ANSSEAU, M., Gonzalez Moreno, A., Hansenne, M., & Wauthy, J. (1992). Evaluation neuroendocrinienne de la fonction catécholaminergique dans le comportement suicidaire. Psychologie Médicale, 24 (11), 1200-1204.
Peer reviewed

ANSSEAU, M., PITCHOT, W., Gonzalez-Moreno, A., Papart, P., Gerritsen van der Hoop, R., & Bradford, D. (1992). Flesinoxan, a 5-HT1A agonist, in major depression: Clinical efficacy and effects on rem latency and body temperature (open study). European Neuropsychopharmacology, 2 (3), 313. doi:10.1016/0924-977X(92)90153-Y
Peer Reviewed verified by ORBi

ANSSEAU, M., PAPART, P., PITCHOT, W., Timsit-Berthier, M., Legros, J.-J., & von Frenckell, R. (1992). Dexamethasone suppression test and prediction of treatment response to selective antidepressants. European Psychiatry, 7 (4), 191-194.
Peer Reviewed verified by ORBi

Ansseau, M. (1992). Diagnostic and therapeutic usefulness of biological markers of depression [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/266202

Ansseau, M., Pitchot, W., Hansenne, M., & Gonzalez Moreno, A. (1992). Psychotic reactions to zolpidem. The Lancet, 339 (8796), 809. doi:10.1016/0140-6736(92)91935-2
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Hansenne, M., & Wauthy, J. (1992). Evaluation neuroendocrienne de la fonction catécholaminergique dans le comportement suicidaire. Psychologie Médicale, 24 (11), 1200-1204.
Peer reviewed

Schittecatte, M., ANSSEAU, M., Charles, G., Machowski, R., Papart, P., PITCHOT, W., & Wilmotte, J. (1992). Growth hormone response to clonidine in male untreated panic patients. Psychological Medicine, 22 (4), 1059-1062. doi:10.1017/s0033291700038630
Peer Reviewed verified by ORBi

PITCHOT, W., Gonzalez Moreno, A., & ANSSEAU, M. (1992). Therapeutic window for 5-HT reuptake inhibitors. The Lancet, 339 (8794). doi:10.1016/0140-6736(92)90858-Z
Peer Reviewed verified by ORBi

PITCHOT, W., Gonzalez Moreno, A., Ansseau, M., Hansenne, M., & Papart, P. (1992). Clonidine test in bipolar vs unipolar melancholic patients. European Neuropsychopharmacology, 2 (3), 306. doi:10.1016/0924-977X(92)90142-U
Peer Reviewed verified by ORBi

PITCHOT, W., Ansseau, M., Réel, C., Gonzalez Moreno, A., Papart, P., & Hansenne, M. (1992). Red blood cell folate and suicidal behavior. European Neuropsychopharmacology, 2 (3), 306-307. doi:10.1016/0924-977X(92)90143-V
Peer Reviewed verified by ORBi

Legros, J.-J., & Ansseau, M. (1992). Neurohypophyseal Peptides and Psychopathology. Progress in Brain Research, 93, 455-460, discussion 461. doi:10.1016/S0079-6123(08)64589-6
Peer Reviewed verified by ORBi

PITCHOT, W., Gonzalez Moreno, A., ANSSEAU, M., & von Frenckell, R. (1992). Relationship between clonidine test and suicidal behavior. European Neuropsychopharmacology, 2 (3), 307. doi:10.1016/0924-977X(92)90144-W
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Hansenne, M., & von Frenckell, R. (1992). Dopaminergic function in panic disorder: comparison with major and minor depression. Biological Psychiatry, 32 (11), 1004-1011. doi:10.1016/0006-3223(92)90061-4
Peer Reviewed verified by ORBi

Hansenne, M., PITCHOT, W., Gonzalez-Moreno, A., von Frenckell, R., & Ansseau, M. (1992). Clonidine test and MMPI scales in major depression : State or trait markers? European Psychiatry, 7 (3), 129-133.
Peer Reviewed verified by ORBi

Legros, J.-J., Geenen, V., Gazzotti, C., Timsit-Berthier, M., & ANSSEAU, M. (1992). Peptides neurohypophysaires et psychopathologie. Revue Française d'Endocrinologie Clinique, Nutrition, et Métabolisme, 33 (2), 115-120.
Peer Reviewed verified by ORBi

ANSSEAU, M., Lembreghts, M., Jammaer, R., Réel, C., Wauthy, J., PITCHOT, W., Gonzalez, M. A., Sulon, J., Legros, J.-J., & Bradford, L. D. (1992). Neuroendocrine responses to intravenous flesinoxan as an index of serotonergic neurotransmission. European Neuropsychopharmacology, 2 (3), 376. doi:10.1016/0924-977X(92)90229-2
Peer Reviewed verified by ORBi

PITCHOT, W., Gonzalez Moreno, A., ANSSEAU, M., & von Frenckell, R. (1992). Growth hormone response to apomorphine test in retarded vs agitated depressed patients. European Neuropsychopharmacology, 2 (3), 307-308. doi:10.1016/0924-977X(92)90145-X
Peer Reviewed verified by ORBi

Legros, J.-J., Gazzotti, C., Carvelli, T., Franchimont, P., Timsit-Berthier, M., von Frenckell, R., & Ansseau, M. (1992). Apomorphine Stimulation of Vasopressin- and Oxytocin-Neurophysins. Evidence for Increased Oxytocinergic and Decreased Vasopressinergic Function in Schizophrenics. Psychoneuroendocrinology, 17 (6), 611-617. doi:10.1016/0306-4530(92)90019-4
Peer Reviewed verified by ORBi

ANSSEAU, M., Caillé, P., Derks, C., Cieren-Puiseux, I., Wauthy, J., Ego, D., Curet, O., Thiola, A., Rovei, V., & Jarreau, F. X. (1992). Phase I study of single ascending doses of befloxatone, a new reversible MAO-A inhibitor antidepressant. European Neuropsychopharmacology, 2 (3), 300. doi:10.1016/0924-977x(92)90133-s
Peer Reviewed verified by ORBi

ANSSEAU, M., Cerfontaine, J.-L., Darimont, P., de Nayer, A. R., Devoitille, J.-M., Dierick, M., Evrard, J.-L., Gérard, M.-A., Kremer, P. J., Lecoq, A., Mertens, C., Mesotten, F., Troisfontaines, B., van Moffaert, M., & Vanbrabant, E. (1992). Nefazodone vs amitriptyline in major depressive inpatients. European Neuropsychopharmacology, 2 (3), 295. doi:10.1016/0924-977X(92)90128-U
Peer Reviewed verified by ORBi

Mesters, P., ANSSEAU, M., Brasseur, R., Bussios, G., Cosyns, P., Czarka, M., De Buck, R., De Frenne, A., Dierick, M., & Linkowski, P. (1992). An open multicentre study to evaluate the efficacy and tolerance of fluoxetine 20 mg in depressed ambulatory patients. Acta Psychiatrica Belgica, 92 (4), 232-245.
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1992). Suicidal behavior and growth hormone response to apomorphine test. Biological Psychiatry, 31 (12), 1213-1219. doi:10.1016/0006-3223(92)90340-6
Peer Reviewed verified by ORBi

Ansseau, M., Pitchot, W., Papart, P., Gonzalez Moreno, A., Lembreghts, M., & Legros, J.-J. (1992). Neuroendocrine Factors in Affective Disorders. Clinical Neuropharmacology, 15 (Suppl 1 Pt A), 574A-575. doi:10.1097/00002826-199201001-00299
Peer Reviewed verified by ORBi

WAUTHY, J., Ansseau, M., von Frenckell, R., Mormont, C., & Legros, J.-J. (01 October 1991). Memory disturbances and dexamethasone suppression test in major depression. Biological Psychiatry, 30 (7), 736-738. doi:10.1016/0006-3223(91)90020-M
Peer Reviewed verified by ORBi

Ansseau, M., Troisfontaines, B., Papart, P., & von Frenckell, R. (28 September 1991). Compulsive Personality as Predictor of Response to Serotoninergic Antidepressants. BMJ: British Medical Journal, 303 (6805), 760-1. doi:10.1136/bmj.303.6805.760
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Gonzalez Moreno, Hansenne, M., papart, P., Gerritsen Van Der Hoop, R., & Bradford, D. (1991). Pilot study of flesinoxan, a 5-HT1A agonist, in major depression. Biological Psychiatry.
Peer Reviewed verified by ORBi

ANSSEAU, M., von Frenckell, R., & Serre, C. (1991). Pilot study of milnacipran in panic disorder. European Psychiatry, 6 (2), 103-105.
Peer Reviewed verified by ORBi

Timsit-Berthier, M., Ansseau, M., Mantanus, H., Schoenen, J., & Legros, J.-J. (1991). Contingent negative variation in psychopharmacology. In C. H. M. Brunia, G. Mulder, ... M. N. Verbater (Eds.), Event related potentials in brain research (pp. 31-45). Amsterdam, Netherlands: Elsevier.

PITCHOT, W., ANSSEAU, M., Gonzales Moreno, A., Papart, P., Gerritsen van der Hoop, R., & Bradford, D. (1991). Pilot study of flesinoxan, a 5-HT1A agonist, in major depression. European Neuropsychopharmacology, 1 (3), 436. doi:10.1016/0924-977x(91)90641-7
Peer Reviewed verified by ORBi

PITCHOT, W., ANSSEAU, M., Gonzalez Moreno, A., Hansenne, M., & von Frenckell, R. (1991). Dopaminergic function in panic disorder. European Neuropsychopharmacology, 1 (3), 464. doi:10.1016/0924-977x(91)90685-n
Peer Reviewed verified by ORBi

Piccinin, B., & Ansseau, M. (1991). Intérêt du sommeil et des tests neuroendocriniens en tant que marqueurs biologiques de la dépression chez l'enfant et l'adolescent. Encéphale (L'), 17 (5, Sep-Oct), 457-466.
Peer Reviewed verified by ORBi

Ansseau, M., Olie, J. P., von Frenckell, R., Jourdain, G., Stehle, B., & Guillet, P. (1991). Controlled Comparison of the Efficacy and Safety of Four Doses of Suriclone, Diazepam, and Placebo in Generalized Anxiety Disorder. Psychopharmacology, 104 (4), 439-443. doi:10.1007/BF02245646
Peer Reviewed verified by ORBi

Ansseau, M., Devoitille, J.-M., Papart, P., Vanbrabant, E., Mantanus, H., & Timsit-Berthier, M. (1991). Comparison of Adinazolam, Amitriptyline, and Diazepam in Endogenous Depressive Inpatients Exhibiting Dst Nonsuppression or Abnormal Contingent Negative Variation. Journal of Clinical Psychopharmacology, 11 (3), 160-165. doi:10.1097/00004714-199106000-00003
Peer Reviewed verified by ORBi

Papart, P., ANSSEAU, M., & Timsit-Berthier, M. (1991). Contingent Negative Variation and response to antidepressants. European Neuropsychopharmacology, 1 (3), 461. doi:10.1016/0924-977X(91)90679-O
Peer Reviewed verified by ORBi

Ansseau, M., & von Frenckell, R. (1991). Intérêt du prazepam gouttes dans le traitement bref des troubles anxieux. Encéphale (L'), 17 (4), 291-294.
Peer Reviewed verified by ORBi

PITCHOT, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1991). Suicidal behavior and growth hormone response to apomorphine test. European Neuropsychopharmacology, 1 (3), 462. doi:10.1016/0924-977x(91)90681-j
Peer Reviewed verified by ORBi

PITCHOT, W., Hansenne, M., Charles, G., Machowski, R., ANSSEAU, M., Gonzalez Moreno, A., Schittecatte, M., Wilmotte, J., & Mirel, J. (1991). P300 in posttraumatic stress disorder: preliminary results. European Neuropsychopharmacology, 1 (3), 465-466. doi:10.1016/0924-977X(91)90687-P
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., & Ansseau, M. (1991). The lack of relationship between DST nonsuppression in the dexamethasone suppression test and EEG abnormalities. European Archives of Psychiatry and Clinical Neuroscience, 241 (3), 193-4. doi:10.1007/BF02219721
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., & Ansseau, M. (1991). The clonidine test in posttraumatic stress disorder. American Journal of Psychiatry, 148 (6), 810-811. doi:10.1176/ajp.148.6.810b
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Gérard, M.-A., Mertens, C., De Wilde, J., Botte, L., Devoitille, J. M., Evrard, J. L., De Nayer, A., & Orban, P. (1991). Interest of a Loading Dose of Milnacipran in Endogenous Depressive Inpatients. Comparison with the Standard Regimen and with Fluvoxamine. European Neuropsychopharmacology, 1 (2), 113-121. doi:10.1016/0924-977x(91)90712-4
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., & Papart, P. (1991). Pilot Study of Pk 11195, a Selective Ligand for the Peripheral-Type Benzodiazepine Binding Sites, in Inpatients with Anxious or Depressive Symptomatology. Pharmacopsychiatry, 24 (1), 8-12. doi:10.1055/s-2007-1014425
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., & Franck, G. (December 1990). Aspects pratiques de l'utilisation des antidépresseurs. Revue Médicale de Liège, 45 (12), 597-613.
Peer reviewed

Papart, P., & ANSSEAU, M. (1990). Milnacipran in obsessive-compulsive disorder: Study in one case. Psychiatrie et Psychobiologie, 5 (5), 325-327.
Peer Reviewed verified by ORBi

von Frenckell, R., Ansseau, M., Serre, C., & Sutet, P. (1990). Pooling Two Controlled Comparisons of Milnacipran (F2207) and Amitriptyline in Endogenous Inpatients. A New Approach in Dose Ranging Studies. International Clinical Psychopharmacology, 5 (1), 49-56. doi:10.1097/00004850-199001000-00005
Peer Reviewed verified by ORBi

Ansseau, M., Papart, P., Gérard, M.-A., von Frenckell, R., & Franck, G. (1990). Controlled Comparison of Buspirone and Oxazepam in Generalized Anxiety. Neuropsychobiology, 24 (2), 74-78. doi:10.1159/000119464
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Moreno, A. G., von Frenckell, R., & Ansseau, M. (1990). Psychopathological correlates of dopaminergic disturbances in major depression. Neuropsychobiology, 24 (4), 169-72. doi:10.1159/000119481
Peer Reviewed verified by ORBi

von Frenckell, R., ANSSEAU, M., Dulcire, C., & Waintraub, L. (1990). Effects of tianeptine on vigilance and memory in young healthy volunteers. Psychiatrie et Psychobiologie, 5 (6), 375-380. doi:10.1177/0269881115573810
Peer Reviewed verified by ORBi

PITCHOT, W., & Ansseau, M. (1990). Aspects pratique de l'utilisation des antidépresseurs. Revue Médicale de Liège, 45 (12), 597-613.
Peer reviewed

Papart, P., Ansseau, M., Devoitille, J. M., Mantanus, H., & Timsit-Berthier, M. (1990). Contingent negative variation and severity of depression. In Psychiatry: A world perspective - Volume 2 (pp. 402-408). Elsevier Science Publishers.
Peer reviewed

Ansseau, M., & von Frenckell, R. (1990). Controlled Comparison of Two Anxiolytic Benzodiazepines, Cloxazolam and Bromazepam. Neuropsychobiology, 24 (1), 25-29. doi:10.1159/000119038
Peer Reviewed verified by ORBi

Charles, G., & ANSSEAU, M. (1990). Les critères de diagnostic pour la recherche en psychatrie (RDC) et le guide pour le diagnostic des troubles affectifs et de la schizophrénie (SADS). Acta Psychiatrica Belgica, 90 (5-6), 225-238.
Peer Reviewed verified by ORBi

Papart, P., & Ansseau, M. (1990). Milnacipran et trouble obsessionnel-compulsif: étude d'un cas. Psychiatrie et Psychobiologie, 5 (5), 325-327.
Peer Reviewed verified by ORBi

Legros, J.-J., & Ansseau, M. (1989). Increased Basal Plasma Vasopressin-Neurophysin in Mania. Hormone Research, 31 (1-2), 55-58. doi:10.1159/000181087
Peer Reviewed verified by ORBi

Machowski, R., ANSSEAU, M., Charles, G., Schittecatte, M., & Wilmotte, J. (1989). Latencies of rem sleep and awakening in major depression: Possible indicators of cholinergic activity. Neurophysiologie Clinique, 19 (5), 385-391. doi:10.1016/S0987-7053(89)80091-7
Peer Reviewed verified by ORBi

ANSSEAU, M. (1989). Les relations anxiété-sommeil et leur incidence en pharmacologie clinique. Psychologie Médicale, 21 (6), 765-773.
Peer reviewed

PITCHOT, W., ANSSEAU, M., PAPART, P., Franck, G., & Rorive, G. (1989). Hyponatrémie induite par la carbamazépine et affection rénale : à propos d'un cas. Psychiatrie et Psychobiologie, 4 (4), 235-237. doi:10.1017/S0767399X00002807
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Mertens, C., de Wilde, J., Botte, L., Devoitille, J. M., Evrard, J. L., De Nayer, A., Orban, P., & Dejaiffe, G. (1989). Controlled Comparison of Two Doses of Milnacipran (F 2207) and Amitriptyline in Major Depressive Inpatients. Psychopharmacology, 98 (2), 163-8. doi:10.1007/BF00444686
Peer Reviewed verified by ORBi

Couvreur, V., Ansseau, M., & Franck, G. (1989). L'électroconvulsivothérapie et ses mécanismes d'actions. Acta Psychiatrica Belgica, 89 (1-2, Jan-Apr), 96-109.
Peer Reviewed verified by ORBi

ANSSEAU, M., von Frenckell, R., Papart, P., Mertens, C., De Wilde, J., Botte, L., Devoitille, J.-M., Evrard, J. L., De Nayer, A., Koch‐Bourdouxhe, S., Darimont, P., Lecoq, A., Mirel, J., Couzinier, J. P., Demarez, J. P., & Serre, C. (1989). Controlled comparison of milnacipran (F2207) 200 mg and amitriptyline in endogenous depressive inpatients. Human Psychopharmacology, 4 (3), 221-227. doi:10.1002/hup.470040308
Peer Reviewed verified by ORBi

ANSSEAU, M. (1988). Le traitement pharmacologique de l'anxiété. Revue Médicale de Liège, 43 (3), 80-91.
Peer reviewed

ANSSEAU, M., & Franck, G. (1988). Vers une méthodologie objective en psychopathologie: l'apport des nouveaux systèmes diagnostiques de la psychométrie et de la psychiatrie biologique. Acta Medicinae Legalis et Socialis, 38 (2), 151-167.
Peer Reviewed verified by ORBi

Ansseau, M., Bataille, M., Bobon, D., Cerfontaine, J.-L., Charles, G., Couteaux, F., Diricq, S., Fraipont, J., Gernay, P., & Troisfontaines, B. (1988). Evaluation de l'activité clinique de la fluoxetine (Prozac) selon "les étoiles de Liège". Acta Psychiatrica Belgica, 88 (2), 127-37.
Peer Reviewed verified by ORBi

Geenen, V., Adam, F., Baro, V., Mantanus, H., Ansseau, M., Timsit-Berthier, M., & Legros, J.-J. (1988). Inhibitory influence of oxytocin infusion on contingent negative variation and some memory tasks in normal men. Psychoneuroendocrinology, 13 (5), 367-375. doi:10.1016/0306-4530(88)90043-1
Peer Reviewed verified by ORBi

Mantanus, H., Ansseau, M., Legros, J.-J., & Timsit-Berthier, M. (1988). Relation entre le test de suppression à la dexaméthasone et la variation contingente négative chez des patients déprimés majeurs. Neurophysiologie Clinique, 18 (4), 345-353. doi:10.1016/s0987-7053(88)80091-1
Peer Reviewed verified by ORBi

ANSSEAU, M. (1988). Les antidépresseurs. Médecine et Hygiène, 46 (1759), 2314-2321.
Peer Reviewed verified by ORBi

Jacqmin, P., & ANSSEAU, M. (1988). Comparison of sublingual and oral prazepam in normal subjects. II. Pharmacokinetic and pharmacodynamic data. Neuropsychobiology, 19 (4), 186-191. doi:10.1159/000118458
Peer Reviewed verified by ORBi

ANSSEAU, M., von Frenckell, R., & Legros, J.-J. (1988). Reply to Swartz [letter to the editor]. Psychiatry Research, 24 (3), 361. doi:10.1016/0165-1781(88)90116-3
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1988). Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. British Journal of Psychiatry, 153 (1), 65-71. doi:10.1192/bjp.153.1.65
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Franck, G., Reynolds, C. F., & Kupfer, D. J. (December 1987). Sommeil et dépression: vers une standardisation de l'utilisation de la latence du sommeil paradoxal en tant que marqueur biologique de dépression majeure. Revue d'Électroencephalographie et de Neurophysiologie Clinique, 17 (4), 411-24. doi:10.1016/S0370-4475(87)80087-4
Peer Reviewed verified by ORBi

Timsit-Berthier, M., Mantanus, H., Ansseau, M., Devoitille, J. M., Dal Mas, A., & Legros, J.-J. (1987). Contingent Negative Variation in Major Depressive Patients. Electroencephalography and Clinical Neurophysiology. Supplement, 40, 762-771.
Peer Reviewed verified by ORBi

D'haenen, H., de Weert, D., & ANSSEAU, M. (1987). Lack of effects of hospitalization and oral contraceptives on DST results in control subjects. Biological Psychiatry, 22 (12), 1499-1502. doi:10.1016/0006-3223(87)90113-2
Peer Reviewed verified by ORBi

Papart, P., & Ansseau, M. (1987). Echelle manie-depression de l'AMDP et inversion maniaque. Psychiatrie et Psychobiologie, II (3).
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1987). Neuroendocrine evaluation of catecholaminergic neurotransmission in mania. Psychiatry Research, 22 (3), 193-206. doi:10.1016/0165-1781(87)90034-5
Peer Reviewed verified by ORBi

ANSSEAU, M., Cerfontaine, J.-L., von Frenckell, R., Charles, G., Papart, P., & Franck, G. (1987). L'index de Newcastle pour le diagnostic de dépression endogène : Comparaison avec les critères de diagnostic pour la recherche de dépression majeure. Encéphale (L'), 13 (2), 67-72.
Peer Reviewed verified by ORBi

ANSSEAU, M., Depauw, Y., Charles, G., Castro, P., D'Haenen, H., De Vigne, J.-P., Hubain, P., Legros, J.-J., Pelc, I., Toscano, A., Wilmotte, J., & Mendlewicz, J. (1987). Age and gender effects on the diagnostic power of the DST. Journal of Affective Disorders, 12 (3), 185-191. doi:10.1016/0165-0327(87)90025-5
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., & Jacqmin, P. (1987). Comparison of Sublingual and Oral Prazepam in Normal Subjects. I. Clinical Data. Neuropsychobiology, 18 (2), 77-82. doi:10.1159/000118397
Peer Reviewed verified by ORBi

Ansseau, M., Legros, J.-J., Mormont, C., Cerfontaine, J.-L., Papart, P., Geenen, V., & Franck, G. (1987). Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology, 12, 231-236. doi:10.1016/0306-4530(87)90009-6
Peer Reviewed verified by ORBi

Demey-Ponsart, E., Ansseau, M., Sulon, J., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Geenen, V., & Legros, J.-J. (1987). Diagnostic performance of basal free cortisol/18-hydroxy-11-deoxy-corticosterone (18-OH-DOC) ratio in endogenous depression: comparison with the dexamethasone suppression test. Biological Psychiatry, 22 (8), 947-956. doi:10.1016/0006-3223(87)90004-7
Peer Reviewed verified by ORBi

ANSSEAU, M. (1987). Troubles du sommeil et affections psychiatriques. Revue Médicale de Liège, 42 (20), 826-831.
Peer reviewed

Legros, J.-J., Geenen, V., & Ansseau, M. (1987). Le point actuel sur l'utilisation de la vasopressine et de l'ocytocine en psychiatrie. Médecine et Hygiène, 45, 2169-2177.
Peer Reviewed verified by ORBi

Papart, P., Ansseau, M., Cerfontaine, J.-L., & Franck, G. (May 1986). Adinazolam-Induced Mania. American Journal of Psychiatry, 143 (5), 684-685. doi:10.1176/ajp.143.5.684-a
Peer Reviewed verified by ORBi

Legros, J.-J., & ANSSEAU, M. (1986). Vasopressin-neurophysin and bipolar depression. Biological Psychiatry, 21 (12), 1212-1216. doi:10.1016/0006-3223(86)90226-X
Peer Reviewed verified by ORBi

ANSSEAU, M. (1986). Les troubles anxieux : Diagnostic et traitement. Médecine et Hygiène, 44 (1666), 2090-2094.
Peer Reviewed verified by ORBi

Charles, G., ANSSEAU, M., Sulon, J., Demey-ponsart, E., Meunier, J.-C., Wilmotte, J., & Jean-jacques, L. (1986). Free cortisol and the dexamethasone suppression test. Biological Psychiatry, 21 (5-6), 549-552. doi:10.1016/0006-3223(86)90199-X
Peer Reviewed verified by ORBi

von Frenckell, R., ANSSEAU, M., & Bonnet, D. (1986). Evaluation of the sedative properties of PK 8165 (Pipequaline), a benzodiazepine partial agonist, in normal subjects. International Clinical Psychopharmacology, 1 (1), 24-35. doi:10.1097/00004850-198601000-00004
Peer Reviewed verified by ORBi

Ansseau, M., Geenen, V., Franck, G., & Legros, J.-J. (1986). Dexamethasone suppression test and MMPI scales. Neuropsychobiology, 16 (2-3), 68-71. doi:10.1159/000118300
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1986). Blunted growth hormone response to clonidine and apomorphine challenges in endogenous depression. In C. Shagass (Ed.), Biological psychiatry : proceedings of the IVth world congress of biological psychiatry, September 8th through 13th, 1985 in Philadelphia (pp. 793-795). New York, United States: Elsevier.

Timsit-Berthier, M., Mantanus, H., Marissiaux, P., Ansseau, M., Doumont, A., Geenen, V., & Legros, J.-J. (1986). CNV and dopamine receptor reactivity: correlations with the apomorphine test. In W. C. McCallum (Ed.), Cerebral psychophysiology: Studies in event-related potentials (pp. 403-405). New York, United States: Elsevier.

ANSSEAU, M. (1986). Les marqueurs biologiques de la dépression. Revue Médicale de Liège, 41 (9), 349-360.
Peer reviewed

ANSSEAU, M., von Frenckell, R., Simon, C., Sulon, J., Demey-Ponsart, E., & Franck, G. (1986). Prediction of cortisol response to dexamethasone from age and basal cortisol in normal volunteers: A negative study. Psychopharmacology, 90 (2), 276-277. doi:10.1007/BF00181258
Peer Reviewed verified by ORBi

ANSSEAU, M., Reynolds III., C. F., Kupfer, D. J., Poncelet, P.-F., Franck, G., Dresse, A., & Reznik, M. (1986). Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 47 (6), 320-321.
Peer Reviewed verified by ORBi

Ansseau, M., De Schepper, P., D'Haene, H., Dresse, A., Godderis, I., Harvengt, C., Herman, A., & Pelc, I. (21 October 1985). Les benzodiazépines dans le traitement de l'anxiété diurne : aspects pharmacologiques, la question de la dépendance, aspects cliniques [Paper presentation]. Retranscription intégrale de la table ronde qui s'est tenue au château de la Hulpe le 21 octobre 1985.

ANSSEAU, M., Diricq, S., & Bataille, M. (1985). Une physionomie comparée originale de l'activité clinique des antidépresseurs. Acta Psychiatrica Belgica, 85 (5), 644-661.
Peer Reviewed verified by ORBi

ANSSEAU, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Demonceau, G., Legros, J.-J., & Franck, G. (1985). Intérêt de l'EEG de sommeil en tant que marqueur biologique des états dépressifs. Comparaison avec trois tests neuro-endocriniens. Revue d'Électroencephalographie et de Neurophysiologie Clinique, 14 (4), 343-349. doi:10.1016/S0370-4475(85)80059-9
Peer Reviewed verified by ORBi

Ansseau, M., Reynolds, C. F. I., Kupfer, D., Doumont, A., Geenen, V., Dresse, A., & Juorio, A. (1985). Extrapyramidal signs following zimelidine overdose. Journal of Clinical Psychopharmacology, 5 (6), 347-348. doi:10.1097/00004714-198512000-00010
Peer Reviewed verified by ORBi

ANSSEAU, M., Kupfer, D. J., Reynolds III, C. F., & Coble, P. A. (1985). "Paradoxical" shortening of REM latency on first recording night in major depressive disorder: Clinical and polysomnographic correlates. Biological Psychiatry, 20 (2), 135-145. doi:10.1016/0006-3223(85)90073-3
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., Thiry, D., von Frenckell, R., & Collard, J. (1985). Initial study of methylclonazepam in generalized anxiety disorder - Evidence for greater power in the cross-over design. Psychopharmacology, 87 (2), 130-135. doi:10.1007/BF00431795
Peer Reviewed verified by ORBi

Ansseau, M. (1985). Intérêt de la latence du sommeil paradoxal en tant que marqueur biologique des états dépressifs : Comparaison avec trois tests neuroendocriniens [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/266411

Geenen, V., Langer, G., Koïnig, G., Schönbeck, G., Ansseau, M., von Frenckell, R., & Legros, J.-J. (1985). Release of human neurophysin I during insulin-induced hypoglycemia is abolished after recovery with clomipramine treatment. Psychoneuroendocrinology, 10 (1), 61-69. doi:10.1016/0306-4530(85)90039-3
Peer Reviewed verified by ORBi

ANSSEAU, M. (1985). BENZODIAZEPINES ET SOMMEIL. Acta Psychiatrica Belgica, 85 (4), 522-532.
Peer Reviewed verified by ORBi

Brasseur, R., van Moffaert, M., Mesotten, F., ANSSEAU, M., Uytdenhoef, P., & Bartholome, F. (1985). A Belgian multicentre study of fluvoxamine in depressive outpatients. Acta Psychiatrica Belgica, 85 (5), 636-643.
Peer Reviewed verified by ORBi

ANSSEAU, M., Kupfer, D. J., & Reynolds, C. F. (1985). Internight variability of REM latency in major depression: Implications for the use of REM latency as a biological correlate. Biological Psychiatry, 20 (5), 489-505. doi:10.1016/0006-3223(85)90021-6
Peer Reviewed verified by ORBi

Ansseau, M., Doumont, A., Cerfontaine, J.-L., Sulon, J., Demey-Ponsart, E., Geenen, V., & Legros, J.-J. (1985). Diagnostic performance of the thirty-four hour dexamethasone suppression test. Psychoneuroendocrinology, 10, 215-219. doi:10.1016/0306-4530(85)90060-5
Peer Reviewed verified by ORBi

ANSSEAU, M., Machowski, R., Franck, G., & Timsit-Berthier, M. (1985). REM sleep latency and contingent negative variation in endogenous depression suggestion for a common cholinergic mechanism. Biological Psychiatry, 20 (12), 1303-1307. doi:10.1016/0006-3223(85)90115-5
Peer Reviewed verified by ORBi

ANSSEAU, M., Thiry, D., & Doumont, A. (1984). Klinische studie van Lormetazepam 2mg bij slaapstoornissen van gehospitaliseerde psychiatrische patiënten. Ars medici: Internationaal tijdschrift voor praktische therapie, 39 (1), 46-51.
Peer reviewed

ANSSEAU, M., Doumont, A., Cerfontaine, J.-L., Mantanus, H., Rousseau, J.-C., & Timsit-Berthier, M. (1984). Self-reports of anxiety level and EEG changes after a single dose of benzodiazepines: Double-blind comparison of two forms of oxazepam. Neuropsychobiology, 12 (4), 255-259. doi:10.1159/000118148
Peer Reviewed verified by ORBi

ANSSEAU, M., Ansoms, C., Beckers, G., Bogaerts, M., Botte, L., De Buck, R., Diricq, S., Dumortier, A., Jansegers, E., Owieczka, J., & Stellamans, G. (1984). Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression. Journal of Affective Disorders, 7 (3-4), 287-296. doi:10.1016/0165-0327(84)90050-8
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., von Frenckell, R., & Collard, J. (1984). Duration of benzodiazepine clinical activity: Lack of direct relationship with plasma half-life - A comparison of single vs divided dosage schedules of prazepam. Psychopharmacology, 84 (3), 293-298. doi:10.1007/BF00555201
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., von Frenckell, R., & Collard, J. (1984). A long-acting benzodiazepine is more effective in divided doses [letter to the editor]. New England Journal of Medicine, 310 (8), 526. doi:10.1056/NEJM198402233100813
Peer Reviewed verified by ORBi

ANSSEAU, M., Kupfer, D. J., Reynolds III, C. F., & McEachran, A. B. (1984). REM latency distribution in major depression: Clinical characteristics associated with sleep onset REM periods. Biological Psychiatry, 19 (12), 1651-1666.
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., & Diricq, S. (1984). Methodology required to show clinical differences between benzodiazepines. Current Medical Research and Opinion, 8 (s4), 108-114. doi:10.1185/03007998409109548
Peer Reviewed verified by ORBi

ANSSEAU, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Legros, J.-J., & Franck, G. (1984). Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: A pilot study. Psychiatry Research, 12 (3), 261-272. doi:10.1016/0165-1781(84)90031-3
Peer Reviewed verified by ORBi

ANSSEAU, M., Sulon, J., Doumont, A., Cerfontaine, J.-L., Legros, J.-J., Sodoyez, J.-C., & Demey-Ponsart, E. (1984). Use of saliva cortisol in the dexamethasone suppression test. Psychiatry Research, 13 (3), 203-211. doi:10.1016/0165-1781(84)90035-0
Peer Reviewed verified by ORBi

ANSSEAU, M., & Diricq, S. (1983). Lormetazepam and amobarbital sodium in the outpatient treatment of insomnia: A controlled trial. Clinical Therapeutics, 5 (4), 365-376.
Peer Reviewed verified by ORBi

Ansseau, M., Doumont, A., Thiry, D., Geenen, V., & Legros, J.-J. (1983). Interest of 5-hydroxytryptophan (5-HTP) test as a neuroendocrine marker of depressive illness. Acta Psychiatrica Belgica, 83 (1), 50-56.
Peer Reviewed verified by ORBi

ANSSEAU, M. (1983). Comparaison de l'effet anxiolytique du prazepam selon deux schemas d'administration. Ars Medici, 38 (4), 267-277.

ANSSEAU, M., Doumont, A., Thiry, D., & Gelders, Y. (1983). Pilot study of a specific serotonergic antagonist, pirenperone, in the treatment of anxiety disorders. Acta Psychiatrica Belgica, 83 (5), 517-524.
Peer Reviewed verified by ORBi

ANSSEAU, M., Thiry, D., & Doumont, A. (1983). Etude clinique du lormetazepam 2mg dans l'insomnie des patients psychiatriques hospitalisés. Ars Medici, 38 (17-18), 1131-1145.
Peer reviewed

Legros, J.-J., Ansseau, M., Doumont, A., Geenen, V., & van Wimersma-Greidanus, T. (1983). Relationship between vasopressin, neurophysin and ACTH, cortisol plasma levels in non suppressor patients during dexamethasone suppression tests. Neuro Endocrinology Letters, 5 (5), 297-302.
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., & Cerfontaine, J.-L. (1982). De la necessite du diagnostic standardise dans la recherche en psychiatrie biologique. Essai d'integration des 'research diagnostic criteria' dans le systeme AMDP. Acta Psychiatrica Belgica, 82 (4), 422-440.
Peer Reviewed verified by ORBi

ANSSEAU, M. (1982). De benzodiazepinen: van farmacologie tot kliniek Een praktische benadering. Ars Medici, 11 (5), 389-405.

Bobon, D., Mormont, C., Doumont, A., Mirel, J., Bonhomme, P., Ansseau, M., Pellet, J., Pull, C., de Buck, R., Gernay, P., Mormont, I., Lang, F., Lejeune, J., Bronckart, C., & von Frenckell, R. (1982). Analyse factorielle de la révision française de l'échelle A.M.D.P. : résultats d'une étude internationale de 388 cas. Acta Psychiatrica Belgica, 82 (4), 371-389.
Peer Reviewed verified by ORBi

ANSSEAU, M., Dawson, A. F., & Champion, F. (1982). The use of high dose lormetazepam in psychiatric in-patients. Current Medical Research and Opinion, 7 (9), 598-600. doi:10.1185/03007998209110103
Peer Reviewed verified by ORBi

ANSSEAU, M. (1982). Les benzodiazépines : de la pharmacologie à la clinique, une approche pratique. Ars Medici, 37 (4), 241-257.

ANSSEAU, M. (1981). Biological rhythms and behavior. Neuropsychobiology, 7 (5), 280. doi:10.1159/000117859
Peer Reviewed verified by ORBi

Collard, J., & ANSSEAU, M. (1981). A research network of walloon psychiatrists working both on in- and out-patients for specialists and general practitioners. Advances in the Biosciences, 31 (C), 119-124.
Peer reviewed

ANSSEAU, M., Diricq, S., Grisar, T., & Collard, J. (1981). The malignant syndrome of neuroleptics: neuroendocrine and biochemical approaches. Neuroendocrinology Letters, 3 (2), 124.
Peer reviewed

ANSSEAU, M., & Diricq, S. (1981). Lormetazepam et amobarbital dans le traitement ambulatoire de l'insomnie : Une étude contrôlée. Acta Psychiatrica Belgica, 81 (6), 580-594.
Peer Reviewed verified by ORBi

ANSSEAU, M., Diricq, S., Grisar, T., & Collard, J. (1980). Biochemical and neuroendocrine approaches to a malignant syndrome of neuroleptics. Acta Psychiatrica Belgica, 80 (5), 600-606.
Peer Reviewed verified by ORBi

Collard, J., Diricq, S., & ANSSEAU, M. (1979). A comparative controlled clinical study of butriptyline (Evadyne), in standard and sustained-release formulations, in the treatment of depression. Pharmatherapeutica, 2 (4), 260-264.
Peer Reviewed verified by ORBi

Contact ORBi